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GENERAL INTRODUCTION 
T-2 mycotoxln is a CrichoChecene secondary metabolite produced 
primarily by Fusarium species growing on cereal grains in the temperate 
1 2 
climatic zones of North America, Europe, and Asia, ' and is associated 
3 
with a wide variety of human and animal intoxications. The known 
biological effects include severe skin irritation, vomiting, diarrhea, 
feed refusal, inhibition of DNA, RNA, and protein synthesis, and damage 
to hematopoietic and lymphoid cells.^ The documented results of this 
mycotoxlcosis have been reduced growth rates, immunosuppression, and 
deaths of domestic animals^and poultry,^ as well as immunosuppres-
18 9 
sion and deaths of humans. ' ' Using improved methods of chemical 
detection, T-2 toxin has been demonstrated to occur in foods and feeds 
and ingestion of these materials by man or other animals could 
10 
ultimately lower resistance to disease. 
Aspergillosis is a disease of avian species, domestic animals, and 
humans and is caused primarily by Aspergillus fumigatus Fresenius.^^ 
Although the disease is most common in avian species with severe annual 
economic losses to the poultry Industry in the United States, pulmonary 
aspergillosis and mycotic abortion in cattle and guttural pouch mycosis 
in horses are important forms of aspergillosis in domestic 
12 13 
animals. ' In humans, aspergillosis is manifested In three ways: 
allergic, noninvasive, and invasive.In the Immunocompromised 
individual, opportunistic A. fumigatus is able to colonize the lungs, 
invade blood vasculature, cause Infarcts and be disseminated throughout 
the body. 
The widespread occurrence of T-2 toxln-produclng fungi In foods 
and feed and the ubiquitous and pathogenic nature of A. fumlgatus, 
suggest that harmful Interactions may occur In animals, humans, and 
poultry. This study was undertaken to test T-2 toxin vitro and in 
vivo for effects on the phagocytic and cell-mediated immune response to 
A. fumlgatus and on other physical parameters in the rabbit. Natural 
routes of exposure, i.e., oral T-2 dosages and aerosolization of A. 
fumlgatus conldia, were utilized. 
This dissertation consists of two manuscripts to be submitted to 
The American Journal of Veterinary Research. A general summary and 
discussion follows the second manuscript. Literature cited in the 
dissertation Introduction, literature review, general summary, and 
discussion appear at the end of the dissertation. 
The Ph.D. candidate, Kayleen Ann Niyo, was the principal investi­
gator for each study. 
LITERATURE REVIEW 
Trlchothecene mycotoxlns The trichothecenes are a chemically 
related group of fungal secondary metabolites comprising the largest 
group of mycotoxlns.The name trlchothecene^^ was based on the 
origin of the first compound Isolated, trlchothecln. Identified as a 
result of screening cultures of Trlchotheclum roseum for metabolites 
with antifungal activity.More than 68 naturally occurring 
trlchothecene derivatives have been Isolated and characterized as a 
result of the quest for antifungal and antileukemic agents, 
18 
antibiotics, cytotoxlns, phytotoxins, and animal toxins. 
All of the fungi known to produce trichothecenes are members of 
the Fungi Imperfecti, with teleomorphlc stages, when known, belonging 
to the Class Ascomycetes, Pyrenomycetes, Orders Hypocreales or 
19 Xylariales. This suggests a close natural taxonomlc relationship of 
these fungi that produce trlchothecene mycotoxlns. These toxic metabo­
lites are produced by 8 of the 9 species of Fusarlum recognized by 
20 Snyder and Hansen. These species are plant pathogens that infect 
primarily cereal grains in the temperate climatic zones of North 
1 2 America, Europe, and Asia ' and are associated with animal and human 
intoxications throughout the world. Trichothecenes have been isolated 
from species of Trlchotheclum, Trlchoderma, Myrothecium, Stachybotrys, 
Cephalosporlum, Cyllndrocarpon, Verticimonosporium, and Calonectrla 
18 (teleomorph of F^. nivale and F^. rigldlusculum). 
Fungal biosynthesis of the trichothecenes begins with mevalonate, 
derived from three molecules of acetyl coenzyme A. Mevalonate is 
metabolized by the usual pathway of lipid biosynthesis to isopentenyl-, 
19 geranyl-, and farnesyl-pyrophosphates. The latter intermediates are 
then converted into the basic trichothecene molecule. The resulting 
family of secondary metabolites (trichothecenes) are known generally as 
sesquiterpenes and are characterized by the tetracyclic 12,13-epoxy-
trichothec-9-ene nucleus (scirpene). 
Natural trichothecenes are neutral lipid-like materials that are 
19 
soluble in polar organic solvents. They are chemically stable to 
moderate variations in temperature, exposure to light, air, and pH, 
although they are hydrolyzed by strong alkalis and rearranged by strong 
acids. 
Naturally occurring trichothecenes are divided into four groups 
18 (A, B, C, or D) according to their structural features. Important 
members of Group A include; • T-2 toxin, HT-2 toxin, diacetoxyscirpenol, 
and neosolaniol; Group B; nivalenol, deoxynivalenol, trichothecin; 
Group C: verrucarin A, roridin A; and Group D; crotocin. 
T-2 mycotoxin T-2 mycotoxin [3a-hydroxy-4(J,15-diacetoxy-
8ct-(3-methylbutyryloxy)-12,13-epoxytrichothec-9-ene] is the best known 
21 
and most widely studied toxin of the trichothecenes. The known 
producers of T-2 toxin and its related compounds are Fusarium 
sporotrichioides Sherb. [^. tricinctum (Corda) Sacc.], poae (Peck) 
Wollenw., £. semitectum Berk, and Rav., £. sambucinum Fuckel, F. 
equiseti (Corda) Sacc. sensu Gordon, while possible producers are jF. 
graminearum Schwabe, JF. oxysporum Schlecht. emend. Snyd. and Hans., F^. 
lateritium Nees, F. acuminatum Ell. and Ev. sensu Gordon, F. culmorum 
5 
22 (W. G. Smith) Sacc., and F^. moniliforme Sheldon. Natural production 
of the toxin by the fungus tends to occur in grain overwintered in the 
field and in high-moisture grains that have been improperly stored 
following a wet, cold harvest season. These grains are a hazard to 
humans and animals when ingested. 
Analytic detection of T-2 in foodstuffs, tissues, and fluids has 
been reviewed recently.Of the biological assays, the skin test 
23 is the most simple and reliable. Physical methods of analysis 
include thin-layer chromatography (detection limit of 100 ng), reverse-
phase high-performance liquid chromatography (detection limit of 1 yg), 
gas chromatography (detection limit of 10 ng), and gas chromatographic 
18 
mass spectrometric analysis (sensitivity of 5 ppb). Immunochemical 
methods of analysis have recently been developed for T-2 toxin. An 
antibody (Ab) to the toxin^^ has been used in a radioimmunoassay (RIA) 
25 for quantification of T-2 toxin in milk and urine and in corn and 
wheat^^ (sensitive to 0.5 to 2.5 ppb). Antibody has also been used to 
detect T-2 in an enzyme-linked Immunosorbent assay (ELISA) (detection 
27 limit of 2.5 pg). However, the specificity of the Ab precludes their 
use for detecting the many unconjugated and glucuronide conjugated 
metabolites of T-2 toxin. Diagnosis of intoxications caused by T-2 
toxin may be complicated by the fact that often multiple toxins are 
present in contaminated foodstuffs. 
Historically, there have been several major disease outbreaks of 
fungal origin that are suspected to be T-2 or trichothecene-related. 
In 1891, Woronin described a "staggering grain toxicosis" that occurred 
6 
28 in the Ussuri district in eastern Siberia. This syndrome was mani­
fested by nausea, vomiting, vertigo, and visual symptoms in humans who 
consumed toxic millet and barley infected with roseum and caused 
feed refusal in farm animals. 
Alimentary toxic aleukia (ATA) was a serious human intoxication 
that occurred in 1942-47 when over 10% of the population in the 
Orenburg district near Siberia were killed by consuming field over-
8 9 
wintered toxic millet, barley, and wheat. ' Joffe, in retrospective 
studies,^ concluded that the fatalities were due to ingestion of T-2 
toxin produced in these overwintered grains by F^. sporotrichioides and 
£. poae. 
Bean-hull poisoning of horses in Hokkaido, Japan, caused 10-15% 
fatalities within 2-3 days after ingestion and the bean hulls were 
found to be contaminated by jF. sporotrichioides, the major T-2 toxin 
3 22 producer. ' In Japan, Akakabi-byo (red mold disease or scab) of 
wheat, barley, oats, rye, and rice that may affect greater than one-
third of the national production, is probably caused by several myco-
22 toxins, including T-2 toxin. 
In 1972, Hsu £l.^ were the first to identify T-2 toxin in 
extracts of moldy corn that caused death of 5 of 30 dairy cattle in 
Wisconsin. Petrie^^^l.^ identified T-2 as the cause of a similar 
hemorrhagic syndrome in dairy cattle in Britain. Fusariotoxicosis in 
29 poultry is also attributable to T-2 toxin. 
More recently, allegations have been made that T-2 toxin was used 
30 31 
as a chemical warfare agent in southeast Asia. ' Others attributed 
•> if' 
7 
32 the "yellow rain" to pollen or bee feces. Reports have confirmed the 
presence of T-2 toxin and polyethylene glycol, probably used as an 
31 
emulsifier, in the yellow rain samples. Samples of blood, urine, and 
feces of Iranian soldiers subjected to a gas attack during the 
Iran-Iraq War contained detectable T-2 toxin, as well as other 
33 trichothecenes. 
Biochemically, the mechanism of action for T-2 toxin is not fully 
understood. The toxin is thought to be an amphipathic molecule and to 
interact initially with the outer phospholipid bilayer of the 
cell.^^~^^ The possible binding of T-2 to protein receptors on the 
cell membrane may interfere with signal transfer and thus with DNA, 
37-39 
RNA, and protein synthesis. T-2 is characterized by its ability 
to inhibit protein chain initiation in intact ribosomes.^^'^^ Both 
resting and mitogen-stimulated murine lymphocytes were affected by T-t2, 
with resting cells requiring a longer period to demonstrate the effect 
37 than actively dividing cells. At greater dosages, T-2 may lyse cell 
41 
membranes with <5.5 A lesions; lysis may result by formation of free 
radicals.Most studies have shown that proliferative cells^^ and 
cells containing many free polysomes^^ (hematopoietic, lymphoid, intes­
tinal crypt, and bursa of Fabricius) are more susceptible to T-2 
toxin^^*^^ than are parenchymal tissue cells (liver and kidney) that 
have no proliferative undifferentiated cells and few free polysomes. 
The effects of T-2 toxin on mitochondrial respiration are incon­
sistent in in vitro studies. Inhibition of oxygen consumption at sites 
8 
I and 111 were noted in two studies using high concentrations of T-2 
toxin.50,51 
Studies using radiolabeled T-2 toxin indicated that the toxin is 
rapidly metabolized by the liver and eliminated into the intestinal 
tract through the biliary excretion system primarily as glucuronide-
metabolite conjugates.Prior to the present two studies 
46 
reported herein, pathological changes had not been seen in the liver. 
Results from studies on the mutagenic and carcinogenic activity of 
18 
T-2 toxin are contradictory. Evidence of single strand breaks in 
DNA,^^ lymphocyte and fibroblast chromosomal structural aberrations,^^ 
and tumors^^ suggest the need for further study in this area. Terato­
genic effects have been known to occur, and T-2 readily crosses the 
58 placenta. 
The major effect of T-2 toxin is on hematopoietic and lymphoid 
cells with a resultant immunosuppressive effect. JCn vitro studies have 
demonstrated that T-2 toxin decreases chemotactic migration of neutro-
phils^^'^^ and phagocytosis by alveolar macrophages in­
creases skin graft rejection time, inhibits mitogen-induced blasto-
genesis of human lymphocytes without mutagenic activity, 
inhibits platelet function,and is cytotoxic to 
lymphocytes.38'46.48.49,67-70 
Several ^  vivo studies with T-2 toxin have produced variable 
results depending on the species of experimental animal, and the route, 
a m o u n t ,  a n d  d u r a t i o n  o f  t o x i n  a d m i n i s t r a t i o n . A  
few investigators have examined the vivo chronic effects of T-2 
9 
74 toxin on cell mediated resistance to an Infectious disease. T-2 
toxin decreased resistance to mycobacterial infection in mice,^^ 
increased mortality in chickens challenged with Salmonella spp.,^^ 
increased susceptibility to herpes simplex virus in mice,^^ and in­
creased mortality in mice due to listeriosis.Few researchers 
have investigated the interaction of mycotoxins with mycotic disease. 
Aspergillosis The genus name Aspergillus was first used by 
Micheli in his "Nova Plantarum Genera" of 1729 to denote 9 fungal 
species.Presently, about 600 species have been described in the 
genus Aspergillus.They are among the most common fungi of many 
environments throughout the world. However, only about 8 species are 
consistently involved in infectious disease, with A. fumigatus being 
11 79 the most common pathogen. * 
Aspergillus fumigatus Fres., is a member of the Fungi Imperfecti, 
Form Order Moniliales, and Form Family Monlliaceae. The teleomorphic 
state of A. fumigatus is not known, but the closely related species A. 
fischeri has been placed in the Class Ascomycetes, Subclass 
Plectomycetidae, Order Eurotiales, Family Eurotiaceae, and Genus 
80 Sartorya as flscheri. 
Aspergillus fumigatus grows rapidly on Sabouraud dextrose agar 
incubated at 30°C and can be identified on the basis of its colony 
characteristics and microscopic morphology.It is thermotolerant 
and grows at temperatures >45°C. 
In 1815, Mayer and Emmert first described a fungal infection in 
the lungs of a jay (Corvus glandarius).Fresenius introduced the 
S«' S?"' 
10 
term "aspergillosis" in describing a fungal infection in the air sac of 
a bustard (Otis tardaga) from the Frankfort Zoo. He named the fungus 
isolate Aspergillus fumigatus.^ ^ Human Aspergillus pneumomycosis was 
first described by Sluyter in 1847.^^ The classic pathology paper by 
Virchow in 1856 accurately described A. fumigatus as the etiologic 
agent in human aspergillosis.^^ 
Aspergillosis is usually manifested as a pulmonary disease and is 
recognized as having three categories: (1) allergic aspergillosis, (2) 
noninvasive aspergillosis, and (3) invasive aspergillosis.^^ 
Allergic aspergillosis has been defined recently as having two 
forms and its frequency is established.^^ The first form occurs in 
atopic individuals manifested as either asthma, a Type I hypersensi­
tivity, or as allergic bronchopulmonary aspergillosis (ABA), a Type I 
and III (Arthus). hypersensitivity. Asthma involves, only the airways, 
possesses an eosinophllia, and is IgE mediated. There is no precipi­
tating Ab (IgG) produced. ABA causes an Arthus reaction in the endo­
thelium and IgG is present in the serum. The second form of allergic 
aspergillosis occurs in nonatopic individuals and is known as extrinsic 
allergic alveolitis involving both Type III and Type IV hypersensi­
tivity. This disease affects the lung parenchyma rather than the 
airways. Several species of Aspergillus, including A. clavatus, A. 
flavus, and A. fumigatus, may be causative agents. Persons, such as 
farmers, miners, and grain workers, who are exposed to dusty, moldy 
Inhalants can develop the disease, i.e., farmer's lung (actinomycetes 
82  
and A. fumigatus) and malt worker's disease (A. clavatus). Type IV 
11 
hypersensitivity is considered to be involved because a delayed type 
hypersensitivity can be elicited with a subcutaneous injection of Ag. 
Continued exposure to the organism(s) can lead to chronic and 
irreversible fibrosis in the lung. 
Noninvasive aspergillosis (aspergilloma) results from colonization 
of a preexisting cavity present in the lung caused by the other 
11 79 diseases such as tuberculosis or sarcoidosis. ' Conidia are 
inhaled, germinate, and grow to form a "fungus ball." Conidiophores 
and conidia may be produced within the cavity. The fungus usually 
remains contained within the cavity and does not invade blood vessels. 
Invasive aspergillosis may be either chronic necrotizing or 
disseminated disease.Chronic necrotizing aspergillosis is a less 
severe form of invasive aspergillosis lasting one to six months. This 
form does not invade blood vessels, but causes local pulmonary 
necrosis. Diabetics, persons with connective tissue disorders, chronic 
lung disease, inactive tuberculosis, malnourished Individuals, or 
individuals on low dosages of corticosteroids or other immunosuppres­
sants are possible candidates for this form of invasive aspergillosis. 
Cavitation can be seen radiographically. 
Disseminated aspergillosis is considered a disease brought about 
by medical practices where immunosuppressive drugs are used or where 
11 79 the patient is immunocompromised by other factors. ' The patient is 
placed at risk by any disease or treatment that depresses the phago­
cytic cell (macrophage and neutrophil) numbers or functions, or the 
cell mediated immune response of the lymphocytes, primarily the T 
12 
lymphocytes and their lymphoklnes [macrophage inhibition factor (MIF), 
macrophage chemotactic factor (MCF), interleukin 2 (IL-2), leukocyte 
inhibition factor (LIF), leukocyte chemotactic factor (LCF), and 
others]. In disseminated pulmonary aspergillosis the organism invades 
blood vasculature, causes infarcts, and becomes disseminated throughout 
the body. The causative organism may be found in most organs, with the 
brain and gastrointestinal tract being favored, but also liver, kidney, 
and spleen are likely sites for isolation of the organism. 
The major group of individuals at risk for disseminated pulmonary 
aspergillosis are those with acute or chronic myelogenous lymphocytic 
79 leukemia. The resulting neutropenia decreases the efficient 
83 destruction of A. fumigatus hyphae by neutrophils. Individuals with 
lymphomas and other solid tumors are also prone to develop disseminated 
aspergillosis, indicating the importance of lymphocyte-directed cell 
mediated immunity in combating invasion by A. fumigatus. The increased 
use of antibiotics, glucocorticosteroids, and immuno- and 
myelosuppressive drugs in chemotherapy and transplantation patients in 
recent years has also caused a dramatic increase in disseminated 
pulmonary aspergillosis second only to candidiosis as a cause of 
death. 
Aspergillus lung disease can occur in humans regardless of host 
immune status, either in its allergic or noninvasive forms, or occa­
sionally as invasive aspergillosis.However, the manifestation of 
the disease is usually linked to the immune status of the host.^^ 
13 
Because Ab may be absent In these Immunosuppressed patients, the 
ID test is unreliable as a means of immunodiagnosis. Other more 
sensitive assays, i.e., primary binding tests such as solid-phase 
radioimmunoassay (SP-RIA),^^ ELISA,^^ and countercurrent immunoelectro-
89 phoresis have been used experimentally. Immunodiagnosis has also 
been accomplished by the ELISA or RIA detection of galactomannan 
90 
antigenemia. 
There are several major problems encountered in serodiagnosis of 
aspergillosis. Aspergillus antigens are complex mixtures of protein 
and polysaccharide components, making it difficult to obtain comparable 
79 preparations even under controlled conditions within one laboratory. 
Shared antigenicity among Aspergillus species and other microorganisms 
can influence serodiagnosis.^^ Cross-reactivity has been found among 
various species of Aspergillus. Shared antigens also have been found 
among Aspergillus, other fungi, mycobacteria, bacteria, house dust 
mite, and house dust preparations. Cross-reactivity is thought to be a 
result of the polysaccharide antigens. 
Mammalian pulmonary aspergillosis occurs quite frequently in 
12 13 
cattle. ' The condition is manifested by bronchitis and peribron­
chitis arising from focal degenerative changes of bronchial epithelium 
with subsequent sloughing of infected cells. Inflammatory cells may 
fill the alveoli, and nodules of infected cells occur scattered 
throughout the lung. A severe bronchitis may ensue with the formation 
of a mycelial mat along portions of the bronchial wall and, with 
91 
continued tissue reaction, the smaller bronchi may become plugged. A 
14 
specific type of lesion known as an "asteroid body" was originally 
92 described In bovine aspergillosis. Asteroid bodies consist of a 
small portion of fungal hyphae surrounded by eosinophilic clubs. These 
bodies possessed a fibrous capsule and were surrounded by lymphocytes, 
13 79 
neutrophils, and histiocytes. ' 
As mentioned earlier, A. fumlgatus readily invades blood vessels 
and thrombosis is a frequent occurrence in acute cases of bovine 
pulmonary aspergillosis. This phenomenon may be Important in the 
pathogenesis of bovine mycotic abortion, the most economically impor­
tant aspect of aspergillosis of cattle. Annual losses in the state of 
93 South Dakota due to this disease have been estimated at $175,000. It 
94 is economically Important in foreign countries also. Evidence of the 
interrelationship of the pathogenesis of pulmonary aspérgillosis and 
mycotic abortion is that both conditions often occur in the same 
animal;^^*^^ however, experimental production of mycotic abortion has 
not been achieved with A. fumlgatus given to animals by the pulmonary 
route. 
Pulmonary aspergillosis or mycotic abortion has been described in 
other species such as the horse and pig, but are of infrequent or rare 
12,13 
occurrence. 
Guttural pouch mycosis is a common disease in horses that is 
caused primarily by A. fumlgatus and A. nldulans conidia produced in 
13 bedding or feed. Infections form a diptheritlc membrane within the 
guttural pouch and may spread to major blood vessels and nerves at the 
15 
base of the skull, causing symptoms such as ocular defects and facial 
paralysis. 
Aspergillosis is a common and economically important disease in 
avian species^^'^^ with economic losses estimated to be approximately 
$50 million annually to the turkey industry in the United States. 
Infections occur in poultry without any apparent preexisting decreased 
resistance of the host. 
The research literature is voluminous relating to aspergillosis in 
humans having defects in cell mediated immunity,and these phenomena 
97 
occur in mammalian aspergillosis as well. However, few researchers 
have investigated the interaction of mycotic disease with naturally 
consumed immuno- and myelosuppressive agents such as mycotoxins.^^ 
Two studies have shown that use of the trichothecene, diacetoxy-
98 
scirpenol, enhanced the course of experimental candidosis and 
99 
cryptococcosis in mice. Because both Aspergillus and mycotoxins are 
omnipresent in the environment and in foodstuffs, the potential for 
detrimental interaction in animals and humans exists. 
16 
SECTION I. EFFECTS OF T-2 MYCOTOXIN INGESTION ON PHAGOCYTOSIS OF 
ASPERGILLUS FUMIGATUS CONIDIA BY RABBIT ALVEOLAR 
MACROPHAGES AND ON HEMATOLOGIC, SERUM BIOCHEMICAL, AND 
PATHOLOGIC CHANGES IN RABBITS 
17 
Effects of T-2 Mycotoxln Ingestion on Phagocytosis 
of Aspergillus fumlgatus Conldla by Rabbit Alveolar Macrophages 
and on Hematologic, Serum Biochemical, and Pathologic Changes 
in Rabbits 
K.A. Niyo^, MS, J.L. Richard^, PhD, Y. Nlyo^, DVM, PhD, 
and L.H. Tiffany^, PhD 
^National Animal Disease Center, Agricultural Research Service, 
United States Department of Agriculture, P.O. Box 70,'Ames, lA 50010. 
2 Department of Veterinary Pathology, College of Veterinary 
Medicine, Iowa State University, Ames, lA 50011. 
3 Department of Botany, Iowa State University, Ames, lA 50011. 
18 
SUMMARY 
Rabbits were given T-2 mycotoxin orally at 0, 0.25, 0.5, and 
0.75 mg/kg/d for 3 weeks. Deaths (4 of 5 rabbits) occurred in only the 
0.75 mg/kg/d group. Alveolar macrophages (AM) were harvested on Day 22 
and used for ^  vitro phagocytosis of killed Aspergillus fumigatus 
Pres. conidia. The cultures included sera from either untreated or T-2 
treated rabbits. Phagocytosis was significantly reduced (p<0.01) in 
cultures using serum from 0.5 mg/kg/d T-2 treated rabbits and AM from 
either untreated or T-2 treated rabbits. There was little reduction in 
phagocytosis when AM from T-2 treated rabbits and normal serum were 
used. Ingestion of 0.5 mg/kg/d T-2 toxin significantly reduced 
(p<0.05) weight gains, serum alkaline phosphatase (ALP), serum sorbitol 
dehydrogenase (SDH), and serum bacteriostasis. T-2 toxin at 0.75 
mg/kg/d significantly reduced (p<0.05) packed cell volume (PCV), total 
WBC and differential leukocyte counts except for neutrophil counts 
which declined, but not significantly (0.05<p<0.10). Significant 
changes were not detected in alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), blood urea nitrogen (BUN), or complement. 
Histopathologic changes consisting of centrolobular hepatocellular 
swelling, mild portal and periportal fibrosis and lymphocyte necrosis 
within secondary lymphoid tissues occurred in most T-2 treated rabbits. 
Thymic atrophy, bile duct reduplication, and lymphocyte depletion of 
secondary lymphoid tissues occurred in the 0.75 mg/kg/d group. The 
severity of lymphoid depletion in secondary lymphoid tissues occurred 
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In the following order; appendix > sacculus rotundus > Ileal Peyer's 
patch > lymph nodes and spleen. 
This study provides additional evidence that at these oral dosages 
of T-2 toxin, rabbits could be immunosuppressed as evidenced by reduced 
AM phagocytosis and histopathologic changes In lymphoid tissues, and 
that these dosages caused reductions in weight gains, certain 
hematologic parameters, and serum ALP and SDH levels. 
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INTRODUCTION 
The trichothecenes are the major toxic secondary metabolites that 
1 2 
are produced by several Fusarium spp. * Most research with 
trichothecenes has been done with T-2 toxin, diacetoxyscirpenol, and 
deoxynivalenol, primarily using cattle, swine, and poultry. The 
2 
effects of these toxins have been grouped into four categories as 1) 
feed refusal, 2) dermal necrosis, 3) gastrointestinal effects, and 4) 
coagulopathy. 
Another important effect of T-2 toxin is that of immuno­
suppression. Turkeys were more susceptible to T-2 toxin than chickens 
3 
and this toxin caused a decrease in the size of lymphoid organs. 
Depletion of thymic cortical lymphocytes occurred in turkeys fed 10 ppm 
dietary T-2 toxin. T-2 toxin has been demonstrated to affect various 
immune phenomena including the functional capacity of phagocytic cells, 
4 
especially neutrophils. In vitro studies with T-2 toxin have 
demonstrated inhibition of chemotaxis and phagocytosis by rat 
leukocytes,^ and Buening ££ found a depression of chemotaxis by 
neutrophils from orally dosed cattle. Bactericidal activity by 
neutrophils was depressed in monkeys dosed orally with T-2 toxin.^ 
Phagocytosis has been decreased by other mycotoxins, such as 
g 
aflatoxins. Richard and Thurston demonstrated reduced phagocytosis by 
AM from rabbits fed various dosages of aflatoxin for 3 weeks and the 
reduction was greatest when serum from treated rabbits was incorporated 
in the tissue culture assay system. Aflatoxin inhibited phagocytosis 
of latex particles and uptake and incorporation of labeled leucine and 
21 
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uridine by rat liver macrophages. Because T-2 toxin has been shown to 
depress several immune phenomena, we investigated the possible 
interference of this compound with phagocytosis by AM from rabbits fed 
T-2 toxin for 21 days. 
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MATERIALS AND METHODS 
Animals Twenty New Zealand white female rabbits (Small Stock 
Industries, P.O. Box 157, Pearidge, AR) each weighing approximately 2 
kg were used in this study. They were housed in individual cages and 
given food (Laboratory Rabbit Diet #0533, Teklad, Winfield, lA 52659) 
and water ad libitum. 
T-2 toxin Crystalline T-2 toxin was prepared from extracts of 
white corn-meal Inoculated with Fusarium sporotrichioides Sherb. NRRL 
3299 [F. trlcinctum (Corda) Sacc.J according to the method of 
Burmeister.Purity was determined to be 97% by thin-layer 
chromatographic and gas chromatographic-mass spectral analyses 
conducted in another laboratory (C.J. Mirocha, University of Minnesota, 
St. Paul, MN). 
T-2 toxin was dissolved in acetone at concentrations that would 
yield 0.1 ml solution of each daily dosage. This amount of solution 
was placed in No. 5 gelatin capsules to provide daily dosages for one 
week. Acetone was allowed to evaporate before assembling the capsule. 
Capsules were stored at 4°C. 
Conidial suspension/serum solution Aspergillus fumigatus Fres. 
conidia were harvested as described by Richard and killed by 
ethylene oxide sterilization. A suspension of conidia in Medium 199 
(M199) was added to serum at a 2:1 ratio yielding a final concentration 
of 2.5 X 10^ conidia/ml. 
Experimental design The rabbits were randomly assigned to 
4 groups of 5 rabbits each according to dosages of T-2 toxin and 
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observed daily throughout the study. Dosage groups included 0, 0.25, 
0.5, and 0.75 mg/kg/d of T-2 toxin. Each rabbit was given either an 
empty capsule (for the 0 dosage group) or a capsule containing T-2 
toxin daily for 21 days with a balling gun. Rabbits were weighed 
weekly and dosages of T-2 toxin were adjusted each week according to 
weight changes. A six ml sample of peripheral blood was obtained 
weekly from each rabbit. Serum was separated by centrifugation, 
removed, and stored at -70°C. On Day 22 of the study, all surviving 
rabbits were euthanatized, and after removal of the lungs, were 
necropsied. Alveolar macrophages were obtained in the following 
manner. The upper trachea was clamped and transected craniad to the 
clamp. After removal of the heart and lungs, the bronchus to the right 
lung was doubly clamped and transected. The right lung was removed, 
perfused with 2% glutaraldehyde in 0.1 M sodium cacodylate, and used 
for microscopy. The left lung was lavaged twice with 30 ml of Hanks 
g 
balanced salt solution (BSS) to obtain AM for the phagocytosis study. 
Phagocytosis assay Macrophages from each rabbit were tested 
for viability by exclusion of 0.125% aqueous Trypan blue. After 
refrigerated centrifugation for 20 min at 1500 rpm, the macrophages 
were resuspended in 40 ml of BSS, adjusted to the density of a i'/5 
McFarland nephelometer tube, and 0.2 ml of the suspension was placed in 
each of the 8 wells of a tissue culture slide (Lab-Tek Products, 
Division of Miles Labs., Inc., Naperville, IL). Macrophages were 
allowed to attach for 20 min at 37°C, rinsed in M199, and 0.2 ml of the 
appropriate conidial suspension/serum solution (Table 1) was placed in 
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Table 1. Combinations of alveolar macrophages and conldial 
suspension/serum solutions used in phagocytosis study 
Macrophages from 
control* or 
T-2 treated 
rabbitsf 
+ M199 conldial suspension 
serum from control! or 
T-2 treated rabbits 
Control rabbits + Control rabbits 
Control rabbits + 0.25 mg T-2/kg/d 
Control rabbits + 0.5 mg T-2/kg/d 
0.25 mg T-2/kg/d + Control rabbits 
0.5 mg T-2/kg/d + Control rabbits 
0.25 mg T-2/kg/d + 0.25 mg T-2/kg/d 
0.5 mg T-2/kg/d + 0.5 mg T-2/kg/d 
Pobled macrophages from control rabbits. 
^Given T-2 toxin orally. 
Î Pooled serum from control rabbits. 
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each well and Incubated at 37°C for 1 h. The cultures were rinsed and 
fixed in absolute methanol for 15 min. The plastic culture chambers 
were removed from the glass slides and cells were stained with Diff 
Quik (American Scientific Products, Div. of American Hospital Supply 
Co., McGaw Park, XL). Approximately 200 macrophages/rabbit (>60/well 
in 3 wells) were examined with a light microscope and the number of 
conidia ingested by each macrophage was recorded. 
Hematologic and serum biochemical determinations Packed cell 
volume (PCV), white blood cell (WBC) counts (using a Coulter counter 
[Coulter Counter, Coulter Electronics, Hialeah, FL]) and differential 
counts were determined on each blood sample. Serum alkaline 
phosphatase (ALP), sorbitol dehydrogenase (SDH), alanine amino 
transferase (ALT), aspartate amino transferase (AST), and blood urea 
nitrogen (BUN) were determined using a centrifical analyzer (Rotachem 
Ila centrifical analyser, Travenol Labs, Inc., Deerfield, IL). 
Complement and bacterlostasis determinations Complement was 
12 titrated on all serum samples, using a 50% hemolytic end point. 
Serum bacterlostasis of a strain of Escherichia coli was measured using 
13 the method of Thurston e£ ad. Rabbit serum was used at a dilution of 
1:4 in phosphate buffered saline solution (pH 7.4). 
Histopathology Portions of kidney, liver, thymus, heart, 
adrenal, spleen, pancreas, Peyer's patch, mesenteric and jejunal lymph 
nodes, sacculus rotundus, appendix, and gastrointestinal tissues were 
fixed in buffered 10% formalin, embedded in paraffin, sectioned at 
5 pm, stained with hematoxylin and eosin (H&E) stain and examined by 
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light microscopy. The right lung was perfused with 2% glutaraldehyde 
in 0.1 M sodium cacodylate, and processed as other tissues. Tissues 
stained with Gomori's one-step trichrome and periodic acid-Schiff's 
were used for evaluating hepatic fibrosis and glycogen, respectively. 
Statistical analysis Group means were compared by standard 
Student's t-test. Time trends were measured and tested by linear 
regression analysis. 
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RESULTS 
Clinical observations Severe physical effects of T-2 toxin 
were observed in the rabbits of the 0.75 mg/kg/d group. After 2 to 
3 days of dosages, these rabbits became lethargic, were apparently 
inappetent, amount of feces decreased markedly, and the fecal pellets 
were small and moist. They had excessive salivation 2 to 4 days before 
death. Fur around the mouth, on the neck, and front limbs became wet 
and tan-stained with saliva. 
Three of the 5 rabbits in this group died 8 to 14 days after 
dosing began, and one was killed in extremis on Day 15. No further 
dosages were given to the fifth rabbit after Day 18 because that group 
could not be used in the phagocytosis study. 
The final 24 hours before death, the rabbits appeared weak and 
felt cool. The difference in rate of body weight gain between the 
control and the 2 greatest dosage groups was significant (p<0.05) 
(Fig. 1). Rabbits given lesser dosages appeared healthy. 
Phagocytosis assay The Trypan blue exclusion test indicated 
that 81% of the macrophages from control rabbits, 72% from the 0.25 
mg/kg/d group, and 57% from the 0.5 mg/kg/d group were viable. The 
number of conidia phagocytized by the macrophages from any dosage group 
was decreased 52% (p<0.01) when serum from the 0.5 mg/kg/d group was 
used in the phagocytosis assay (Table 2). Nonsignificant differences 
in phagocytosis attributed to the macrophages from T-2 treated rabbits 
were noted (Table 2). Similar results were obtained when the data were 
analyzed for the number of macrophages Ingesting conidia and/or the 
Figure 1. Mean body weights (g) of rabbits (5/dosage group) 
given T-2 toxin orally. The 0.75 mg/kg/d group had 5,4,2, 
and 1 rabbits at 0-3 weeks, respectively. The 2 highest 
dosage groups were different from control (p<0.05) 
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Table 2. Mean number of conldia Ingested In one hour by rabbit 
alveolar macrophages (M0) 
M0 from rabbit Serum from rabbit 
dosage groups (mg T-2/kg/d) dosage groups (mg T-2/kg/d) 
0.0 0.25 0.5 
0.0 2.4 1.5 1.1 
0.25 2.4 1.6 ND* 
0.5 2.1 ND 1.1 
2.3^ (0.12) 1.5 (0.9) l.lf (0.11) 
Not Determined. 
^Mean, figure In parentheses Is Standard Error. 
Î p<0.01. 
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number of conldla Ingested/macrophage. The phagocytosis assay was not 
determined with AM from the 0.75 mg/kg/d group because of the high 
mortality rate. 
Hematologic and serum biochemical changes Hematologic changes 
were most severe in the 0.75 mg/kg/d group. The weekly means for PCV, 
WBC, and absolute lymphocyte numbers declined during the 21 day period. 
The declines, as measured by linear regression, were statistically 
significant (p<0.05). After 3 weeks, PCV values (Fig. 2) had decreased 
from 32% to 25%. The total WBC count (Fig. 3) decreased from 4.6 to 
o 
1.4 X 10 /L and the absolute number of lymphocytes (Fig. 4) decreased 
9 from 3.1 to 0.5 x 10 /L. Neutrophil numbers (Fig. 5) declined 
(approaching significance, p<0.09) only in the 0.75 mg/kg/d group from 
9 1.3 to 0.3 X 10 /L. Rabbits in this group had a marked increase in 
nucleated erythrocytes (NRBC) in peripheral blood after the first week 
of treatment. The surviving rabbit had 288 NRBC/100 WBC. 
Polychromasia, poikilocytosis, anisocytosis, echinocytosis, 
acanthocytosis, and basophilic stipling were common findings. No 
changes were noted in other blood cell types. Changes in other dosage 
groups were not significant. 
The reductions in serum ALP (Table 3) and SDH (Table 4) 
concentrations were statistically significant (p<0.05) in the 0.5 
mg/kg/d group by the end of the first week. There were no significant 
changes in ALT, AST, and BUN levels. 
Complement and bacteriostatic effects Bacteriostatic activity 
(Fig. 6) of serum from rabbits in the 0.5 and 0.75 mg/kg/d groups was 
Figure 2. Mean packed cell volume (%) from rabbits (5/dosage group) 
given T-2 toxin orally. The 0.75 mg/kg/d group had 5,4,2, 
and 1 rabbits at 0-3 weeks, respectively, and was different 
from control (p<0.05) 
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Figure 3. Mean total white blood cell counts (N/ul) from rabbits 
(5/dosage group) given T-2 toxin orally. The 0.75 mg/kg/d 
group had 5,4,2, and I rabbits at 0-3 weeks, respectively, 
and was different from control (p<0.05) 
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Figure A. Mean lymphocytes (N/yl) from rabbits (5/dosage group) given 
T-2 toxin orally. The 0.75 mg/kg/d group had 5,4,2, and 1 
rabbits at 0-3 weeks, respectively, and was different from 
control (p<0.05) 
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Figure 5. Mean neutrophils (N/yl) from rabbits (5/dosage group) given 
T-2 toxin orally. The 0.75 mg/kg/d group had 5,4,2, and 1 
rabbits at 0-3 weeks, respectively, and was different from 
control (p<0.09) 
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Table 3. Mean serum alkaline phosphatase (ALP) concentrations (lU/L) 
from rabbits given T-2 toxin orally for 21 days 
Dosage Group (mg/kg/d) 
Week 0 0.25 0.5 0.75 
0 89 81 82 99 
1 91 65 55 53 
2 94 67 45 38 
3 94 57 43 44* 
2.1^ (2.3) -7.6^(2.3) -12.3Î(2.3) 
*Data from one surviving rabbit not treated for last 4 days of 
experiment. 
^Coefficient of linear regression, figure In parentheses Is 
Standard Error. 
fp<0.05. 
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Table 4. Mean serum sorbitol dehydrogenase (SDH) concentrations (lU/L) 
from rabbits given T-2 toxin orally for 21 days 
Dosage Group (mg/kg/d) 
Week 0 0.25 0.5 0.75 
0 32 29 25 27 
1 29 20 16 28 
2 27 17 13 23 
3 25 18 17 21* 
-0.7^(1.0) -3.2^(1.0) -4.3f(1.0) 
Data from one surviving rabbit not treated for last 4 days of 
experiment. 
^Coefficient of linear regression, figure in parentheses is 
Standard Error. 
îp<0.05. 
Figure 6. Bacteriostatic activity (% transmlttance at 540nra for 120m) 
of serum from rabbits (5/dosage group) given T-2 toxin 
orally. The 0.75 mg/kg/d group had 5,4,2, and 1 rabbits at 
0-3 weeks, respectively. The 2 highest dosage groups were 
different from control (p<0.05) 
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significantly reduced (p<0.05 and p<0.01, respectively) by the end of 
the first week. There was no significant change in the 0.25 mg/kg/d 
group. T-2 toxin at the dosages given had no effect on complement 
activity. 
Gross lesions Mucosal petechiation and erosions were observed 
in the stomachs of 2 rabbits given 0.75 mg of T-2 toxin/kg. Gastric 
ulcers were seen in one rabbit in this group. Three of the 5 rabbits 
in the 0.5 mg/kg/d group had hyperemia mucosal areas in their stomachs. 
Gross lesions were not found in either the 0.25 mg/kg/d or the control 
group. 
Histologic lesions Microscopic lesions were confined to liver, 
thymus, and to the secondary lymphoid tissues of the T-2 treated groups 
(Table 5). 
In the 0.25 mg/kg/d group, lesions were limited to the liver, 
ileal Feyer's patches, appendix, and sacculus rotundus. Hepatic 
lesions consisting of centrolobular hepatocellular swelling (Fig. 7) 
and mild portal and periportal fibrosis occurred in 4 of the 5 rabbits. 
Swollen hepatocytes were positive for glycogen. Changes in the 
appendix, sacculus rotundus, and ileal Peyer's patches were 
characterized by scattered areas of lymphocyte necrosis in all 5 
rabbits. Lymphocyte necrosis was centered around the germinal centers 
and was less prominent in the dome area of sacculus rotundus and 
appendix. Mild lymphoid depletion was noted in 2 rabbits. 
Lesions in the 0.5 mg/kg/d group were essentially similar to those 
in the 0.25 mg/kg/d group but were slightly more severe (Fig. 8). 
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Table 5. Frequency of occurrence and location of major microscopic 
lesions in rabbits given T-2 toxin orally for 21 days 
Organ/ Dosage Group (mg/kg/d) 
Tissue Lesions 0.0 0.25 0.5 0.75 
Liver : Hepatocellular 
swelling 0(5)* 4(5) 4(5) 3(4) t  
Portal fibrosis 0(5) 4(5) 4(5) 3(4) 
Bile duct 
proliferation 0(5) 0(5) 0(5) 3(4) 
Appendix; Lymphocyte necrosis 
Lymphoid depletion 
0(5) 
0(5) 
5(5) 
2(5) 
5(5) 
2(5) 
3(4) 
3(4) 
Sacculus 
rotundus: 
Lymphocyte necrosis 
Lymphoid depletion 
0(5) 
0(5) 
5(5) 
2(5) 
5(5) 
2(5) 
4(4) 
3(4) 
Ileal Beyer's 
patches : 
Lymphocyte necrosis 
Lymphoid depletion 
0(5) 
0(5) 
5(5) 
2(5) 
5(5) 
2(5) 
3(4) 
2(4) 
Thymus : Lymphocyte necrosis 
Lymphoid depletion 
0(5) 
0(5) 
0(5) 
0(5) 
0(5) 
0(5) 
2(4) 
2(4) 
Mesenteric: 
lymph nodes: 
Lymphocyte necrosis 
Lymphoid depletion 
0(5) 
0(5) 
1(5) 
0(5) 
1(5) 
0(5) 
2(4) 
2(4) 
Spleen; Lymphocyte necrosis 
lymphoid depletion 
0(5) 
0(5) 
0(5) 
0(5) 
0(5) 
0(5) 
3(4) 
3(4) 
*No. of rabbits with lesions (No. of rabbits examined). 
^Three of 5 rabbits died on Days 8, 11, and 14, respectively, and 
one rabbit was killed in extremis on Day 15. No further dosages were 
given to the fifth rabbit because that group could not be used in the 
phagocytosis study. It was not necropsied on Day 22. 
Figure 7. Centrolobular hepatocellular swelling from a rabbit given 
T-2 toxin orally at 0.25 mg/kg/d for 3 weeks. H&E stain; 
Bar = 40 ym 
Figure 8. Moderate lymphocyte necrosis in appendix from a rabbit 
given T-2 toxin orally at 0.5 mg/kg/d for 3 weeks. H&E 
stain; Bar = 50 ym 
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Microscopic lesions in the 0.75 mg/kg/day group were more severe 
and more extensive than those of the other groups. Liver lesions 
consisted of centrolobular hepatocellular swelling, mild to moderate 
portal and periportal fibrosis (Fig. 9), and mild bile duct 
reduplication. Lymphocyte necrosis was a prominent change in ileal 
Peyer's patches, appendix, sacculus rotundus, mesenteric lymph nodes, 
and spleen. Increased numbers of macrophages and degenerate granular 
leukocytes were present in areas of lymphocyte necrosis within the 
appendix and sacculus rotundus. Lymphoid depletion in mesenteric lymph 
nodes was particularly evident within germinal centers and paracortlcal 
zones while splenic lymphoid depletion was centered around 
periarteriolar sheaths in 3 rabbits. Thymic lesions were observed in 
2 rabbits. They consisted of severe lymphoid depletion (Fig. 10) and 
scattered foci of lymphocyte necrosis. Other lesions observed in this 
group included moderate goblet cell hyperplasia in mucosal epithelium 
of appendix and sacculus rotundus, hyperkeratosis and parakeratosis of 
esophageal mucosa, focal hemorrhages in gastric mucosa, and gastric 
ulcers in one rabbit. 
Figure 9. Portal and periportal fibrosis In liver of a rabbit given 
T-2 toxin orally at 0.75 mg/kg/d for 3 weeks. Gomorl's 
one-step trlchrome; Bar = 100 ym 
Figure 10. Severe lymphoid depletion of thymic cortex from rabbit 
given T-2 toxin orally at 0.75 mg/kg/d for 3 weeks. H&E 
stain; Bar = 100 pm 
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DISCUSSION 
The trypan blue exclusion test Indicated that the effect of 
Ingested T-2 toxin on AM viability is dose dependent. This reduction 
In phagocytic capacity could decrease the effectiveness of the primary 
nonimmunologic and immunologic defense mechanisms in the pulmonary 
system. Although phagocytosis was reduced in AM in the presence of 
homologous serum from rabbits given 0.5 mg T-2 toxin /kg/d, these 
macrophages were capable of normal phagocytosis when serum from control 
rabbits was used in the culture system. Others have shown a reduction 
in AM viability when T-2 toxin was added directly to an vitro 
culture system using rat AM.^^'^^ 
The depression of ^  vitro phagocytosis in this study could be due 
to one or more of the following factors; (1) a metabolite(s) of T-2 
toxin remaining in the serum of treated rabbits; (2) inhibition of 
production or action of serum factors such as opsonins, monokines, or 
lymphokines. In another study, conjugated metabolites of T-2 toxin 
were detected in primarily plasma and the intestinal tract of swine 
given tritium-labeled T-2 toxin intravascularly. 
Immunologic phagocytosis is enhanced by 2 major opsonins, 
immunoglobulins (primarily IgM, IgG^, and IgG^ in humans) and 
17 18 
complement component C3b. ' Others have found decreased IgM and IgG 
7 19 20 levels in monkeys and mice ' and decreased IgM and IgA levels in 
21 
calves given T-2 toxin. The decrease in serum bactericidal activity 
in the present study may indicate a similar effect on Ig, because the 
3 bactericidal reaction was found to be 2.5-10x10 times more sensitive 
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than the agglutination reaction for Ab detection. * Therefore, 
opsonization by Ig may have been affected in the present study. 
Because complement activity was not affected by T-2 ingestion in this 
study, opsonization could have occurred but at reduced efficiency, 
utilizing complement and the C3b receptors on the macrophage leading to 
the Ab-independent alternate pathway mechanism of killing. 
If one or more of the factors discussed above are operable in 
reducing phagocytosis, as assayed in this study, the functional immune 
capacity of the remaining viable macrophages in an animal consuming 
appropriate amounts of T-2 toxin also may be adversely affected. 
This could limit Interleukin 1 (IL-1) production by macrophages, IL-2 
production by T cells, T and B cell proliferation, and functions of 
macrophages and polymorphonuclear leukocytes. Absolute numbers of 
lymphocytes also were decreased in this study and the effect could be 
similar. If other macrophages in the body are similarly affected by 
T-2 ingestion, cell mediated immunity (CMI) could be impaired. 
Our preliminary experiments showed that dosages of 2 mg/kg/d 
caused death of rabbits within 24-48 h. Others have found that high 
doses of T-2 toxin caused shock and subsequent death in other species 
26 27 28 
of animals. ' ' In the present study, 0,75 mg/kg/d produced marked 
physical deterioration within the first week, with the tan, 
saliva-stained fur as the first clinical sign before the rabbits died. 
Because rabbits are coprophagic, reingestlon of T-2 toxin and its 
29 
metabolites that can occur in feces may have caused irritation of the 
mouth resulting in excessive salivation and staining of the fur. 
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The mechanism of action for T-2 toxin is not clear. The toxin is 
thought to be an amphipathic molecule and to interact initially with 
30 31 32 the outer phospholipid bilayer of the cell. * ' The possible 
binding of T-2 to receptors on the cell membrane, may interfere with 
signal transfer and thus with DM, RNÂ, and protein 
synthesis^^*^^*^^*^^ and ultimate reduction of the immune response.^ 
Both resting and mitogen stimulated murine lymphocytes were affected by 
T-2, with resting cells requiring a longer time frame than actively 
33 dividing cells. The effect of long term ingestion of T-2 toxin on 
the lymphoid cells and tissues noted in the present study is consistent 
with these hypotheses. At greater dosages, T-2 may lyse cell membranes 
with formation of <5.5 8. lesions.Concurrently, free radicals that 
are formed may potentiate the direct effect of T-2 toxin on the 
membrane. 
Cells that contain numerous free polysomes (cells that regenerate 
from special proliferating undifferentiated germinal cells and/or blast 
cells; i.e., hematopoietic, lymphoid, intestinal crypt, and bursa of 
Fabricius) apparently are more susceptible to T-2 toxin than cells with 
few free polysomes (parenchymal tissues such as liver and kidney, that 
39 have no proliferative undifferentiated cells). These effects are 
evident in the present study with striking dosage-related 
histopathologic lesions in all lymphoid and gastrointestinal (GI) 
tissues examined. Similar effects were demonstrated in these tissues 
in other studies.The relative severity of 
germinal center lesions in secondary lymphoid tissues was: appendix > 
54 
sacculus rotundus > ileal Peyer's patch) lymph nodes and spleen. This 
reflects the known proliferation rates of lymphoid cells in these 
42 
organs. 
Leukopenia, increases in nucleated erythrocytes, changes in 
erythrocyte morphology, and decreased PCV in rabbits of the 0.75 
mg/kg/d group are indicative of the possible amphipathic nature of T-2 
toxin and its effect on proliferative cell types and the bone marrow 
e n d o t h e l i u m . T h e  2 2 %  d e c r e a s e  i n  P C V  c o u l d  b e  d u e  t o  G I  
hemorrhage or to suppression of hematopoiesis.^^'^^'^^'^^'^^ 
Studies using radiolabeled T-2 toxin indicate that the toxin is 
rapidly metabolized by the liver and eliminated into the intestinal 
tract through the biliary excretion system primarily as glucuronide 
metabolite conjugates.Centrolobular hepatocellular 
swelling and vacuolation, hepatic portal and periportal fibrosis, and 
bile duct reduplication in the present study provide evidence of the 
process. It is possible that the centrolobular hepatocellular swelling 
could have been a reflection of hypoxic change caused by anemia because 
some rabbits were anemic as evidenced by decreased PCV. Decreases in 
serum ALP concentrations may be due to reduced ALP synthesis in the 
32 liver and Intestinal tract, or this decrease may reflect the 
amphipathic nature of T-2 whereby the toxin causes membrane alterations 
without cell lysis and interferes with release of the enzyme from the 
cell.^^ Similar mechanisms may explain the reduced SDH serum 
concentrations. However, SDH is specific for the liver. 
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SECTION II. EVALUATION OF PATHOLOGIC, HEMATOLOGIC, SEROLOGIC, AND 
MYCOLOGIC CHANGES IN RABBITS GIVEN T-2 MYCOTOXIN ORALLY 
AND EXPOSED TO AEROSOLS OF ASPERGILLUS FUMIGATUS FRESENIUS 
CONIDIA 
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SUMMARY 
The influence of immunosuppression in rabbits by T-2 mycotoxin on 
the fungal disease, aspergillosis, was investigated. Rabbits were 
given 0.5 mg T-2 toxin /kg/d orally for 17 or 28 days (Groups 1 and 3) 
and/or exposed to aerosols of Aspergillus fumigatus Pres. conidia from 
Days 7 through 16. One-half of each group were necropsied on Day 17 
and the remaining animals were necropsied on Day 28. Three rabbits 
from Group 1 and one from Group 3 died. Changes caused by T-2 toxin 
included leukopenia, anemia, and increased numbers and morphologic 
changes in nucleated erythrocytes by Day 21, followed by a regenerative 
response. Serum alkaline phosphatase (ALP), serum sorbitol de­
hydrogenase (SDH), and antibody (Ab) response to A. fumigatus, as 
measured by indirect hemagglutination (IHA), were decreased by T-2 
toxin ingestion. Rabbits with aspergillosis had leukocytosis and an 
increased Ab response (IHA) to A. fumigatus. Histopathologic changes 
consisting of centrolobular hepatocellular swelling, portal and 
periportal fibrosis, and lymphocyte necrosis and/or depletion within 
secondary lymphoid tissue occurred in most T-2 treated rabbits. Normal 
defense mechanisms to A. fumigatus infection were compromised by T-2 
treatment, as evidenced by the severity and extent of lung lesions, 
greater number of hyphal elements observed, and greater numbers of A. 
fumigatus colony forming units (CPU) isolated from Group 3 rabbits. 
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INTRODUCTION 
T-2 mycotoxin is a trichothecene secondary metabolite produced by 
Fusarlum species growing primarily on cereal grains in the temperate 
1 2 
climatic zones of North America, Europe, and Asia. ' This toxin has 
been associated with mycotoxicoses characterized by Immunosuppression, 
such as fatal alimentary toxic aleukia in humans,Akakabi-byo (red 
mold) disease in humans and animals in Japan and bean hull poisoning in 
horses in Japan,fusarlotoxicosis in poultry,^ and moldy corn 
9 10 toxicosis in cattle. * 
T-2 toxin is an amphipathic molecule that binds to the cell 
membrane, possibly via receptors,and interferes with DNA,^^ 
RNA,^^ and protein synthesis.At higher dosages, it may lyse 
cell membranes with <5.5 X lesions^^ or possibly cause interaction with 
free radicals that are formed.Proliferative cells^^ and cells 
containing many free polysomes^^ (hematopoietic, lymphoid, intestinal 
crypt, and bursa of Fabrlcius) are more susceptible to T-2 toxin than 
19 24-30 
nonproliferative cells or cells containing few free polysomes. ' 
In vitro studies have demonstrated that T-2 decreases chemotactlc 
31 22 33""35 
migration of neutrophils, * and phagocytosis by AM, increases 
skin graft rejection time,^^ Inhibits mitogen-induced blastogenesls of 
human lymphocytes without mutagenic activity,Inhibits platelet 
function,39 and is cytotoxic to lymphocytes. 
Several ^  vivo studies with T-2 toxin have produced varying results 
depending on the species of experimental animal, and the route, amount, 
and duration of toxin administration.32,40,42 46 ^ few 
66 
studies have examined the vivo chronic effects of T-2 toxin on cell 
47 
mediated resistance to an infectious disease. T-2 toxin decreased 
48 
resistance to mycobacterial infection in mice, increased mortality in 
49 
chickens challenged with Salmonella spp., increased susceptibility to 
50 herpes simplex virus in mice, and increased mortality in mice due to 
listeriosis. 
52 
Aspergillus fumigatus causes aspergillosis in avian species, in 
nonimmunocompromised, nonleukopenic individuals,^^and is a major 
cause of morbidity and mortality in humans with defects in cell-
mediated immunity.Few researchers have investigated the interaction 
of mycotoxins with mycotic disease.Previously, we demonstrated the 
suppressive effect of T-2 toxin ingestion by rabbits on ^  vitro AM 
phagocytosis of A. fumigatus conidia by their alveolar macrophages 
33 (AM). An unknown serum factor appeared to limit phagocytosis by the 
AM. Because the AM is the first line of cellular defense in 
aspergillosis, we tested in vivo effects of T-2 toxin given orally to 
rabbits subsequently challenged with aerosols of A. fumigatus conidia. 
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MATERIALS AND METHODS 
Animals Thirty-six New Zealand white female rabbits (.Small 
Stock Industries, P.O. Box 157, Pearidge, AR) weighing 2.5 to 3 kg were 
used in this study. They were housed in individual cages and given 
food (Laboratory Rabbit Diet #0533, Teklad, Winfield, lA 52659) and 
water libitum. 
T-2 toxin Crystalline T-2 toxin was prepared from extracts of 
white corn-meal inoculated with Fusarium sporotrichioides Sherb. NRRL 
3299 [^. trlcinctum (Corda) Sacc.] according to the method of 
Burmeister.^^ Purity was determined to be 97% by thin-layer chromato­
graphic and gas chromatographic-mass spectral analyses conducted in 
another laboratory (C.J. Mirocha, University of Minnesota, St. Paul, 
MN). 
T-2 toxin was dissolved in acetone at concentrations that would 
yield 0.1 ml solution of each daily dosage. This amount of solution 
was placed in No. 5 gelatin capsules to provide daily dosages for one 
week. Acetone was allowed to evaporate before assembling the capsule. 
Capsules were stored at 4°C. 
Inoculum Aspergillus fumigatus Pres., strain 0073, was used 
for the production of conidia and preparation of antigen for double 
immunodiffusion (ID) tests. This strain was a National Animal Disease 
58 
Center isolate from the gastric contents of an aborted bovine fetus. 
Aspergillus fumigatus var ellipticus (VE) was used to prepare antigen 
59 for the indirect hemagglutination test (IHA). This isolate was 
obtained from a human patient at Cook County Hospital, IL. Methods of 
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growth, collection, and determination of conidial viability have been 
previously reported. 
Experimental design The rabbits were randomly assigned to b 
groups of 6 rabbits each (Table 1). Groups lA and B and 3A and B 
received 0.5 mg/kg/d of T-2 toxin for the duration of the experiment. 
The toxin in capsules was given daily with a balling gun. Rabbits were 
weighed weekly and dosages were adjusted each week according to weight 
changes. Groups 2A and B and 3A and B were exposed to aerosols of A. 
fumigatus conidia for 1/2 hour daily from Days 7 through 16. Groups 
lA, 2A, and 3A were bled 6 and 24 h after time of aerosolization (Days 
16 and 17) and euthanatized on Day 17. Blood and selected tissues were 
subjected to plate counts to determine viable colony forming units 
(CPU) of A. fumigatus. The remaining animals (Groups IB, 2B and 3B) 
were euthanatized on Day 28. 
Aerosol exposure Rabbits from Groups 2 and 3 were confined in 
3 individual wire mesh cages and placed in a clear, plexiglass, 1 m , 
aerosol chamber (Fig. 1) designed to hold 12 cages/aerosolization. 
Conidia (100 mg/15min) were aerosolized into the chamber for 30 min 
exposures each day for 10 consecutive days using an air pump capable of 
displacing 12 L of air/min. The concentration of conidia within the . 
chamber was recorded once a minute with a particle counter (Royco 
Particle Monitor Model 218, Royco Instruments, Inc., Menlo Park, CA) 
set to exclude particles <2 ym in diameter. The level of conidia in 
5 3 the chamber was maintained at >1 X 10 /m /min. From Days 7 to 16, all 
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Table 1. Experimental design for study of the interaction of T-2 
mycotoxin ingestion by rabbits exposed to Aspergillus 
fumlgatus conidia 
T-2 toxin Aerosol Bled for 
Treatment No. in given exposure culture Day 
Groups Group (Days) (Days) (Days) Killed 
1 T-2 only 
lA 6 1-16 ND 16 and 17 17 
IB 6 1-27 ND ND 28 
2 A. furaieatus 
conidia only 
2A 6 ND 7-16 16 and 17 17 
2B 6 ND 7-16 ND 28 
3 T-2 + A., fumleatus 
conldia 
3A 
3B 
1-16 
1-27 
7-16 16 and 17 17 
7-16 ND 28 
3 Figure 1. Chamber (1 m ) for exposure of rabbits to aerosols of 
Aspergillus fumlgatus conldla. Air pumps (A) capable of 
displacing 12 L of alr/mln. Particle counter (B) to 
determine concentration of conldla/m volume of air. 
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rabbits were housed in a room that was positive in pressure and adja­
cent to the aerosol room. 
Personnel protection from aerosol Aerosolization was conducted 
in a room with controlled and filtered airflow. Human exposure to A. 
fumigatus was minimized during handling of rabbits and aerosolization 
by use of full-face safety masks equipped with 0.8 pm filters. Person­
nel wore coveralls that were autoclaved after use and showers were 
taken before donning normal laboratory clothing and exiting the 
facility. 
Hematologic and serum biochemical determinations A six ml 
peripheral blood sample was obtained weekly from each rabbit. Serum 
was separated by centrifugation, collected, and stored at -70°C. 
Packed cell volume (PCV), white blood cell (WBC) counts (using a 
Coulter counter [Coulter Counter, Coulter Electronics, Hialeah, FL]), 
and differential counts were determined on each blood sample. Serum 
alkaline phosphatase (ALP), sorbitol dehydrogenase (SDH), alanine amino 
transferase (ALT), aspartate amino transferase (AST), and blood urea 
nitrogen (BUN) were determined using a centrifical analyzer (Rotachem 
Ila Centrifical Analyzer, Travenol Labs, Inc., Deerfield, IL). Comple­
ment was titrated on all serum samples, using a 50% hemolytic end 
point. 
Serology Antibody (Ab) to A. fumigatus was measured by IHA and 
ID in all sera collected weekly, and from rabbits killed on Day 27. ID 
tests were done on microscope slides using 0.6% agarose gel. 
Aspergillosis fumigatus strain 0073 was grown on neopeptone dyalysate 
73 
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medium, filtered, dialyzed, and lyophilized. The antigen was used at 
a concentration of 20 mg/ml. The IHA test was done as previously 
59 described, at a dilution of 1:16. Sheep red blood cells (SRBC) were 
sensitized with antigen made from cultures of VE because it produces a 
59 better erythrocyte sensitizing antigen than strain 0073. 
Fungal isolation from tissues and blood One ml of blood per 
animal collected aseptically was plated on Sabouraud's dextrose agar 
plates. Selected tissue samples (lung, ileal Peyer's patch, and 
sacculus rotundus) were collected aseptically during necropsy. Tissues 
were weighed in sterile petri plates, placed into sterile TenBroeck 
grinders with sufficient sterile saline solution to produce at 1:10 
(w/v) concentration. Tenfold dilutions of ground tissues in sterile 
saline were plated on Sabouraud's dextrose agar in triplicate 
(1 ml/plate) to determine the average viable CPU of A. fumigatus in the 
rabbit tissues. 
Histopathology Tissue samples from kidney, liver, thymus, 
heart, adrenal, spleen, pancreas, ileal Peyer's patch, mesenteric and 
jejunal lymph nodes, sacculus rotundus, appendix, and gastrointestinal 
tissues were fixed in buffered 10% formalin, embedded in paraffin, 
sectioned at 5 ym, stained with hematoxylin and eosin stain, and 
examined by light microscopy. Lungs were perfused with 2% 
glutaraldehyde in 0.1 M sodium cacodylate, and processed as other 
tissues. Special stains used included Gridley's and Gomori's 
methenamine silver (CMS) for demonstration of fungi and Gomori's 
one-step trichrome for evaluation of hepatic fibrosis. 
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Statistical analysis Group means were compared by standard 
Student's t-test. Time trends were measured and tested by linear 
regression analysis. 
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RESULTS 
Clinical observations Rabbits that died had excessive saliva­
tion 4 to 8 days before death. The fur around the mouth, on the neck, 
and front limbs was wet and tan-stained. These rabbits became 
lethargic and were apparently Inappetent. The amount of feces de­
creased markedly, and the fecal pellets were small and moist. Three 
rabbits in Group 1 died after 11, 12, and 15 days of T-2 dosages. One 
rabbit in Group 3 died on Day 11 (after 11 days of T-2 dosage and 
5 days of aerosolization with A. fumigatus conidia). 
Body weight (Fig. 2) decreased in Groups 1 and 3 and the rate of 
weight gain from Group 2 was significant (p<0.01). 
Hematologic and serum biochemical changes . For most hematologic 
parameters (Table 2, Figs 3-6), Groups 1 and 3 had similar trends that 
were different from Group 2 as determined by linear regression. The 
consistent hematologic trends in rabbits receiving T-2 (Groups 1 and 3) 
were leukopenia, decreased PCV, and increased nucleated erythrocytes 
by Day 21, followed by a regenerative response by Day 28 (with the 
exception of lymphocytes in Group 1). Group 2 rabbits had a 
significant increase (p<0.01) in PCV. Significant increases (<0.05) 
were seen in WBC, neutrophils, and segmented neutrophils of Group 2 
rabbits. Significant decreases (p<0.01) in lymphocytes counts and 
eosinophil counts were seen in Group 1 and 3, respectively. Leukocyte 
counts in Group 1 rabbits decreased (p<0.05). 
Sixteen of 24 rabbits in Groups 1 and 3 had significant increases 
(p<0.05) in nucleated erythrocytes (NRBC) (Fig. 7), ranging from 9 to 
Figure 2. Mean body weights (g) of rabbits given T-2 toxin orally for 
17 or 28 days (Groups 1 and 3) and/or rabbits exposed to 
aerosols of A. fumigatus conidia on Days 7 through 16 
(Groups 2 and 3). Increase in rate of gain for Group 2 was 
significant (p<0.01) 
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Table 2. Sequential changes in body weights and hematologic values of rabbits given T-2 toxin 
orally for 17 or 28 days (Groups 1 and 3) and/or rabbits exposed to aerosols of A. 
fumigatus conidia on Days 7 through 16 (Groups 2 and 3)* 
Days 
Group 0 6 14 21 28 
Body 1 2754 + 52 2778 + 58 2640 + 77 2667 + 99 2675 + 140 
weight (g) 2 2823 T 43 2798 T 46 3035 T 63 3144 + 73 3195 + 146 
3 2782 T 49 2755 T 85 2737 "+ 86 2678 T 103 2644 + 121 
PCV (%) 1 32.3 + 0.7 33.6 + 0.6 31.3 + 0.9 28.4 + 1.6 34.6 + 2.6 
2 32.3 T 1.0 33.9 T 0.5 34.4 T 0.4 34.8 + 1.4 38.0 T 1.3 
3 32.3 + 1.3 33.4 "+ 1.0 30.7 "+ 1.2 31.1 T 1.5 32.8 T 3.0 
WBC 1 5181 + 294 4818 + 424 5711 + 1196 2927 + 256 4175 + 1181 
(N/pl) 2 5571 T 599 5756 T 648 6980 T 409 7713 T 1520 7184 T 1174 
3 4739 T 248 4123 T 409 3648 T 670 2789 T 639 5363 T 789 
Lymphocytes 1 3243 + 168 3240 + 322 2975 + 464 2037 + 345 1996 + 457 
(N/nl) 2 3268 T 246 3554 T 320 4101 T 405 4525 "+ 470 3533 T 1195 
3 2666 T 221 2786 T 261 2537 T 417 2185 T 409 3138 T 481 
Neutrophils 1 1767 + 180 1350 + 167 2970 + 872 892 + 321 2332 + 833 
(N/yl) 2 2223 + 375 2078 + 431 2705 T 283 3610 T 1379 3433 T 566 
3 1851 T 113 1201 T 206 1186 T 272 686 T 242 2388 T 716 
Segmented 1 1699 + 168 1289 + 154 2934 + 864 878 + 322 2319 + 829 
neutrophils 2 2162 T 358 1852 T 387 2600 + 279 3587 T 1383 3414 + 566 
(N/pl) 3 1809 + 116 1141 + 187 1167 +" 276 676 T 244 2330 T 720 
Banded 1 67 + 32 61 + 28 35 + 14 14 + 14 13 + 13 
neutrophils 2 61 + 20 225 + 97 105 + 36 23 + 16 19 + 13 
(N/pl) 3 42 + 16 60 + 27 19 + 7 10 + 9 8 T 8 
Monocytes 1 171 + 38 131 + 36 119 + 61 12 + 7 17 + 8 
(N/yl) 2 191 T 60 133 + 37 112 T 38 20 T 13 12 T 12 
3 161 + 28 93 T 37 27 T 13 29 + 24 21 T 21 
Eosinophils 1 23 + 14 45 + 22 5 + 5 0 0 
(N/iil) 2 26 T 11 116 T 79 12 T 8 6 + 6 0 
3 27 + 8 21 T 9 0 0 0 
Nucleated 1 1 7 + 3 51 + 44 17 + 5 45 + 45 
erythrocytes/ 2 0 2 T 1 4 +" 1 3 + 1 3 T 2 
100 WBC 3 0 8 + 4 55 T 23 122 T 64 15 + 11 
Through Day 14, there were a minimum of 10, 12, and 11 rabbits In groups 1, 2, 
and 3, respectively. On Days 21 and 28, there were 5, 6, and 6 rabbits In groups 1, 2, 
and 3, respectively. 
Figure 3. Mean packed cell volume (%) from rabbits given T-2 toxin 
orally for 17 or 28 days (Groups i and 3) and/or rabbits 
exposed to aerosols of A. fumlgatus conidia on Days 7 
through 16 (Groups 2 and 3). Increase for Group 2 was 
significant (p<0.01) 
81 
GROUP I 
A—^ GROUP 2 
»—# GROUP 3 
-AEROSOLIZED-
r-
6 8 10 12 14 16 18 20 22 24 26 28 
DAYS 
1 I 
2 4 
Figure 4. Mean total white blood cell counts (N/yl) from rabbits given 
T-2 toxin orally for 17 or 28 days (Groups 1 and 3) and/or 
rabbits exposed to aerosols of A. fumigatus conidia on 
Days 7 through 16 (Groups 2 and 3). Decrease for Group 1 
and increase for Group 2 were significant (p<0.05) 
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Figure 5. Mean lymphocytes (N/pl) from rabbits given T-2 toxin orally 
for 17 or 28 days (Groups 1 and 3) and/or rabbits exposed to 
aerosols of A. fumlgatus conldia on Days 7 through 16 
(Groups 2 and 3). Decrease for Group 1 was significant 
(p<0.01) 
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Figure 6. Mean neutrophils (N/nl) from rabbits given T-2 toxin orally 
for 17 or 28 days (Groups 1 and 3) and/or rabbits exposed to 
aerosols of A. fumlgatus conldla on Days 7 through 16 
(Groups 2 and 3). Increase for Group 2 was significant 
(p<0.05) 
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Figure 7. Mean nucleated erythrocytes/100 WBC from rabbits given T-2 
toxin orally for 17 or 28 days (Groups 1 and 3) and/or 
rabbits exposed to aerosols of A. fumigatus conidia on 
Days 7 through 16 (Groups 2 and 3). Increases for Groups 1 
and 3 were significant (p<0.05). (High mean for Group 1 on 
Day 28 due to 224 NRBC/100 WBC in one rabbit.) 
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446 NRBC/100 WBC. Polychromasla, polkllocytosls, anlsocytosis, 
echlnocytosis, acanthocytosis, and basophilic stipling were common 
findings. No changes were noted in other blood cell types. 
The reductions in serum ALP and SDH concentrations (Table 3) in 
Groups 1 and 3 were significant (p<0.01). There were no significant 
changes In ALT, AST, and BUN levels. 
Serology There was no Ab response to A. fumigatus as measured 
by IHA (Table 4) in Group 1 rabbits. In Group 2, 5 of 6 rabbits had Ab 
on Day 17, and 6 of 6 were positive for Ab on Days 21 and 28. In Group 
3, only 1 of 5, 2 of 6, and 1 of 6 rabbits were positive on Days 17, 
21, and 28, respectively. Only 2 rabbits had precipitating Ab (ID 
test) (one rabbit each, in Groups 2 and 3) on Day 28. 
Neither ingestion of T-2 toxin nor aerosollzatlon with A. 
fumigatus conidia appeared to have an effect on serum complement 
activity of the rabbit. 
Fungal isolation from tissues and blood The number of A. 
tumlgatus CFU/g lung tissue (Table 5) was negligible in Group 1 rabbits 
on Days 17 and 28. Group 3 had approximately 80% more CFU/g lung 
tissue than Group 2. Both Groups 2 and 3 had a 99% reduction in the 
number of CFU In lung tissue from Day 17 to 28. On Day 17, there were 
few CFU in ileal Peyer's patch and sacculus rotundus tissues of most 
rabbits in Groups 2 and 3, but by Day 28 no A. fumigatus was recovered. 
Aspergillus fumigatus was Isolated from the blood of only 4 rabbits 
(2 in each of the exposed groups) at 6 h post aerosollzatlon and was 
not isolated at 24 h. 
X*' 
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Table 3. Mean serum alkaline phosphatase (ALP) and sorbitol * 
dehydrogenase (SDH) concentrations (lU/L) from rabbits given 
T-2 toxin orally for 17 or 28 days (Groups 1 and 3) and/or 
rabbits exposed to aerosols of A. fumigatus conldla on Days 7 
through 16 (Groups 2 and 3) 
Group 
Day 1 2 3 
ALP SDH ALP SDH ALP SDH 
0 79 317 65 293 87 396 
6 45 234 72 254 48 195 
14 31 136 58 226 28 133 
17 41 99 54 189 20 100 
21 34 145 56 243 26 172 
28 54 211 55 248 31 147 
50^^ 214$ 62 247 46$ 192$ 
(3.6) (13.9) (2.5) (8.4) (4.0) (14.2) 
* 
Through Day 17, there were a minimum of 10, 12, and 11 rabbits in 
Groups 1, 2, and 3, respectively. On Days 21 and 28, there were 5, 6, 
and 6 rabbits in Groups 1, 2, and 3, respectively. 
i* Mean, figure in parentheses is standard error. 
îp<0.01. 
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Table 4. Antibody response to A. fumigatus (measured by Indirect 
Hemagglutination) of sera from rabbits given T-2 toxin orally 
for 17 or 28 days (Groups 1 and 3) and/or rabbits exposed to 
aerosols of A. fumigatus conidia on Days 7 through 16 (Groups 
2 and 3) 
Group (Treatment) 
Days 
17 21 28 
1 (T-2 toxin) 0(4)* 0(5) 0(5) 
2 (A. fumigatus) 5(6) 6(6) 6(6) 
3 (Both) 1(5) 2(6) 1(6) 
No. of rabbits with positive response (No. of rabbits tested). 
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Table 5. Mean number of colony forming units (CPU) of Aspergillus 
fumlgatus/g In tissues of rabbits given T-2 toxin orally for 
17 or 28 days (Groups 2 and 3) and/or rabbits exposed to 
aerosols of A. fumigatus conidia on Days 7 through 16 
(Groups 2 and 
Tissue 
No. of Payer's Sacculus 
Day Group Rabbits Lung Patch Rotundus 
17 lA 4 0.4 X 10 0 0 
17 2A 6 168 X 10 2.3 6.1 
17 3A 5 776 X 10 0.4 5. 
28 IB 5 0.1 X 10 0 0 
28 2B 6 1.1 X 10 0 0 
28 3B 6 6.0 X 10 0 0 
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Gross lesions Lung lesions were observed in all rabbits 
exposed to A. fumlgatus conldia (Groups 2 and 3). They consisted of 
multiple, firm, tan to grey, nodules widely distributed throughout the 
lung parenchyma. Subpleural nodules tended to be raised above the lung 
parenchyma. The thymus appeared atrophic in 2 rabbits that were 
treated with T-2 toxin (Groups 1 and 3). Two rabbits that died 
(Group lA) and 2 rabbits that were killed (Group 3A) had congested 
gastric mucosa and focal mucosal erosions. Gross lesions were not 
observed in other body organs and tissues examined. 
Microscopic lesions 
Lung Microscopic lung lesions were present in all rabbits 
that had been aerosolized with A. fumigatus conidia (Groups 2 and 3) 
(Table 6). They consisted of multiple, often coalescing, granulomas or 
pyogranulomas composed of masses of epithelioid macrophages, neutro­
phils, lymphocytes, plasma cells, and few multinucleated giant cells. 
These lesions were most prominent within terminal bronchioles and 
associated alveoli. Embedded within some of these granulomas were 
short, radiating and branching hyphae that were often surrounded by a 
mantle of acidophilic homogeneous precipitate. Small clusters of 
epithelioid macrophages and alveolar macrophages containing one or 
several A. fumlgatus conidia were scattered within alveolar spaces at 
the periphery of the granulomas. Type II pneumocyte hyperplasia and 
squamous metaplasia were frequently seen in areas of granuloma forma­
tion. Lung lesions in non-T-2 treated rabbits, aerosolized with A. 
Table 6. Frequency of occurrence and location of major microscopic lesions in rabbits given 
T-2 toxin orally for 17 or 28 days (Groups 1 and 3) and/or rabbits exposed to 
aerosols of A. fumigatus conidia on Days 7 through 16 (Groups 2 and 3) 
Organ/ Necropsied 
Tissue on Day Group Lesion Rabbits 
Lung: 17 lA NSL 
2A Medium granulomas 6(6)^ 
Hyphae and conidia 6(6) 
Increased lymphocytes and plasma cells 6(6) 
Increased neutrophils 6(6) 
3A Large pyogranulomas 5(5) 
Masses of hyphae and conidia 5(5) 
Decreased inflammatory reaction 5(5) 
Lung: 28 IB NSL 
2B Small granulomas 6(6) 
Few hyphae and conidia 2(6) 
Increased lymphocytes and plasma cells 6(6) 
Decreased neutrophils 6(6) 
3B Medium pyogranulomas 3(6) 
Hyphae and conidia 3(6) 
Decreased inflammatory reaction 6(6) 
Liver: 17 lA Centrolobular hepatocellular degeneration 2(4) 
Mild portal fibrosis 1(4) 
2A NSL 
3A Centrolobular hepatocellular degeneration 1(5) 
Mild portal fibrosis 3(5) 
Bile duct reduplication 2(5) 
Liver; 28 IB Centrolobular hepatocellular degeneration 3(5) 
Mild/moderate portal fibrosis 4(5) 
Bile duct reduplication 1(5) 
2B NSL 
3B Centrolobular hepatocellular degeneration 2(6) 
Mild/Moderate portal fibrosis 5(6) 
Bile duct reduplication 5(6) 
Appendix/ 17 lA Mild lymphoid necrosis/depletion 4(4) 
Sacculus 
rotundas : 2A NSL 
3A Moderate/severe lymphocyte necrosis/depletion 5(5) 
Hyphae or conidia 4(5) 
Focal granulomas 4(5) 
Appendix/ 28 IB Mild/moderate lymphocyte necrosis/depletion 5(5) 
Sacculus 
rotundus: 
2B NSL 
SB Moderate/severe lymphocyte necrosis/depletion 6(6) 
No significant lesions. 
"i* No. of rabbits with lesions (No. of rabbits examined). 
Table 6 continued 
Organ/ Necropsied 
Tissue on Day Group Lesion Rabbits 
Ileal Peyer' s 17 lA Mild/moderate lymphocyte necrosis/depletion 4(4) 
Patch: 
2A NSL 
3A Mild/moderate lymphocyte necrosis/depletion 5(5) 
Ileal Peyer' s 28 IB Mild/moderate lymphocyte necrosis 3(5) 
Patch: 
2B NSL 
3B Mild/moderate lymphocyte necrosis 5(6) 
Mesenteric/ 17 lA Mild lymphocyte necrosis/depletion 2(4) 
Jejunal 
Lymph Nodes 2A NSL 
3A Severe lymphocyte necrosis/depletion 2(5) 
Mesenteric/ 28 IB NSL 
Jejunal 
Lymph Nodes 2B NSL 
3B Mild lymphocyte necrosis 2(6) 
Spleen 17 lA Nucleated erythrocytes in red pulp 4(4) 
2A NSL 
3A Mild/moderate lymphocyte necrosis/depletion 2(5) 
Nucleated erythrocytes in red pulp 5(5) 
Spleen 28 IB Nucleated erythrocytes in red pulp 5(5) 
2B NSL 
3B Nucleated erythrocytes in red pulp 6(6) 
Thymus 17 lA Severe lymphoid depletion 1(4) 
2A NSL 
3A Severe lymphoid depletion 1(5) 
Thymus 28 IB Mild lymphoid depletion 1(5) 
2B NSL 
3B NSL 
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fumlgatus conldia and killed on Day 17 (Groups 2A) had larger lung 
granulomas than those rabbits killed on Day 28 (Group 2B). While 
neutrophils constituted a significant cellular component of the larger 
granulomas in Group 2A (Fig. 8), lymphocytes and plasma cells 
predominated in the lesions of Group 2B (Fig. 9). Additionally, fewer 
fungal hyphae and conidia were observed in lung lesions of Group 2B 
than those of Group 2A. 
Lung lesions in Groups 3A and 3B (T-2 treated and aerosolized with 
A. fumigatus conldia) appeared to be more severe and more extensive 
than those of Groups 2A and 2B. In Group 3A, large areas of the lung 
parenchyma had been replaced by irregular masses of granulomatous or 
pyogranulomatous exudate. Although the lesions appeared to be centered 
"within alveoli, terminal bronchioles, and bronchi, some granulomas had 
obliterated all normal parenchymal structures as they expanded outward. 
In some areas, the granulomas had breached mucosal walls of several 
bronchioles and tended to project into their lumens. In other areas, 
bronchiolar lumina were filled with necrotic, amorphous material. The 
centers of many granulomas were necrotic and most contained tangled 
masses of hyphal elements and conidia surrounded by radiating 
acidophilic clubs (Fig. 10). Type II pneumocyte hyperplasia and 
hyperplasia of bronchiolar epithelium were prominent in many areas of 
the lung. Macrophages containing 2 to 10 conidia were frequently found 
in alveoli adjacent to the granulomas. 
Lung lesions in Group 3B were essentially similar to those in 
Group 3A rabbits. However, the granulomas tended to be smaller and 
Figure 8. Medium-sized granuloma In lung of a rabbit exposed to 
aerosols of Â. fumlgatus conldla on Days 7 through 16 and 
necropsled on Day 17 (Group 2A). Neutrophils constitute a 
significant cellular component of the lesion. H&E stain; 
Bar = 50 pm 
Figure 9. Small granuloma In lung of a rabbit exposed to aerosols of 
A. fumlgatus conldla on Days 7 through 16 and necropsled on 
Day 28 (Group 2B). Lymphocytes and plasma cells predominate 
In these lesions. H&E stain; Bar = 50 pm 
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less numerous In Group 3B (Fig. 11) than in Group 3A rabbits. Hyphae 
and conidia were frequently found in the granulomas but they were less 
numerous in Group 3B than in Group 3A. 
Liver Hepatic lesions consisting of centrolobular hepato­
cellular degeneration (Fig. 12) and mild portal fibrosis (Fig. 13) were 
found in approximately one-half of the rabbits in Groups lA and 3A. 
Rabbits treated with T-2 toxin and killed at Day 28 (Groups IB and 3B), 
had more severe hepatic lesions consisting of centrolobular hepato­
cellular degeneration, mild to moderate portal and periportal fibrosis, 
and bile duct proliferation. There were no significant hepatic lesions 
in Groups 2A and 2B rabbits. 
Appendix and sacculus rotundus Changes in the appendix 
and sacculus rotundus of T-2 treated rabbits (Groups 1 and 3) ranged 
from mild to severe lymphocyte necrosis within the dome, corona, and 
lymphoid follicles. Debris-laden macrophages were frequently found in 
areas of lymphocyte necrosis. Small focal granulomas (Fig. 14) were 
found in the appendix and/or sacculus rotundus of 4 rabbits in Group 
3A. Some of these granulomas contained variable numbers of fungal 
hyphae and conidia (Fig. 15). 
Ileal Peyer's patch There was mild to moderate lymphocyte 
necrosis and/or lymphoid depletion In nearly all T-2 treated rabbits 
(Groups 1 and 3). Degenerate macrophages and neutrophils were present 
In areas of lymphocyte necrosis. These changes were most prominent in 
Group 3A rabbits. 
Figure 10. Large pyogranuloma in lung of a rabbit given T-2 toxin 
orally for 17 days, exposed to aerosols of A. fumigatus 
conidia on Days 7 through 16, and necropsied on Day 17 
(Group 3A). Center of granuloma was necrotic and con­
tained tangled masses of hyphae and conldia surrounded by 
radiating acidophilic clubs. H&E stain; Bar = 25 ym 
Figure 11. Medium-sized pyogranuloma in lung of a rabbit given T-2 
toxin orally for 28 days, exposed to aerosols of A. 
fumigatus conidia on Days 7 through 16, and necropsied on 
Day 28 (Group 3B). H&E stain; Bar = 50 pm 
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Figure 12. 
Figure 13. 
Centrolobular hepatocellular degeneration in a rabbit given 
T-2 toxin orally for 28 days, exposed to aerosols of A. 
fumigatus conidia on Days 7 through 16, and necropsied on 
Day 28 (Group 3B). Bar = 50 ym 
Portal and periportal fibrosis in liver from a rabbit given 
T-2 toxin orally for 28 days, exposed to aerosols of A. 
fumigatus conidia on Days 7 through 16, and necropsied on 
Day 28 (Group 3B). H&E stain; Bar = 100 ym 
106 
mm 
Figure 14. Focal collection of macrophages in sacculus rotundus of a 
rabbit given T-2 toxin orally for 17 days, exposed to 
aerosols of A. fumigatus conidia on Days 7 through 16, and 
necropsied on Day 17 (Group 3A). H&E stain; Bar = 50 ym 
Figure 15. Aspergillus fumigatus hyphae in lesion in sacculus 
rotundus of a rabbit given T-2 toxin orally for 17 days, 
exposed to aerosols of A. fumigatus conidia on Days 7 
through 16, and necropsied on Day 17 (Group 3A). H&E 
stain; Bar = 25 pm 
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Mesenteric/j ej unal lymph nodes Lymph node changes 
consisting of mild to severe lymphocyte necrosis or lymphoid depletion 
were observed in only a few T-2 treated rabbits. 
Spleen Lymphocyte necrosis and lymphoid depletion 
occurred in 2 rabbits from Group 3A. Nucleated erythrocyte precursors 
were numerous within the red pulp of all T-2 treated rabbits (Groups 1 
and 3). 
Thymus Severe lymphoid depletion was observed in the 
thymus of one rabbit from Group lA and one rabbit from Group 3A. 
Stomach Gastric mucosal hyperemia, hemorrhage, and 
superficial mucosal necrosis were observed in 2 rabbits from Group 3A 
and rabbits that died early (Group lA). 
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DISCUSSION 
We previously demonstrated that ingestion of T-2 toxin by rabbits 
for 3 weeks caused a depression of in vitro phagocytosis by their AM 
33 due to a serum factor. The AM were decreased in numbers and in 
ability to phagocytlze A. fumlgatus conidia. Another ^  vitro study 
has shown the requirement for a macromolecular serum component(s) 
necessary for full fungistatic capability of activated alveolar 
macrophages. 
The present ^  vivo study demonstrated that ingestion for 17 or 28 
days of 0.5 mg T-2 toxin /kg/d by rabbits and challenge with aerosols 
of A. fumlgatus conidia for 10 consecutive days decreased the cell 
mediated resistance and immune response necessary to combat asper­
gillosis. Changes included reduced AM efficiency, suppression of 
hematopoiesls (with resulting transient anemia and leukopenia), 
lymphocyte necrosis, and depleted lymphoid tissue. 
The rabbit's defense mechanisms to A. fumlgatus infection were 
compromised by T-2 treatment. This was reflected in the severity and 
extent of lung lesions in Group 3 rabbits. Numerous fungal hyphae and 
conidia were observed in Group 3 rabbits killed early (Group 3A) as 
well as in those killed late in the course of the experiment 
(Group 3B). Additionally, focal granulomas containing fungal elements 
were observed in the appendix and sacculus rotundus of these rabbits. 
These changes are evidence of a diminished capacity of the phagocytic 
cells in T-2 treated rabbits to destroy A. fumlgatus. In contrast, the 
much smaller lung granulomas and the relatively fewer fungal elements 
Ill 
observed in Group 2B rabbits suggested a partial resolution of these 
lesions. These findings indicate that normal rabbits are capable of 
mounting effective host defenses against A. fumigatus infection. This 
is in agreement with other researchers.^^ 
Considerably more CFU of A. fumigatus were isolated from T-2 
treated rabbits (Group 3) than from rabbits that were not treated with 
the toxin. This was additional evidence for decreased phagocytic and 
killing ability of alveolar macrophages in the T-2 treated rabbits. 
The diminished cell-mediated resistance to aspergillosis caused by 
T-2 toxin ingestion may be a reflection of the amphipathic effect of 
the toxin^^ primarily on proliferating undifferentiated germinal 
24 
cells and/or blast cells. The toxin is thought to interact initially 
with the outer phospholipid bilayer of the cell, possibly binding to 
the receptors on the cell membrane, interfering with signal transfer, 
and causing decreased RNA, DNA, and protein synthesis.At 
greater dosages, T-2 may lyse cell membranes with formation of <5.5 A 
22 lesions. Concurrently, free radicals that are formed may potentiate 
23 the direct effect of T-2 toxin on the membrane. A decrease in 
33 34 
numbers of AM, ' neutrophils, and other leukocytes and a decrease in 
synthesis of monokines or lymphokines would suppress the cellular 
response to the disease. 
The Ab response of Group 3 rabbits to A. fumigatus, as measured by 
IHA, may be a result of lymphopenia. This could cause a decrease in 
T-helper cell numbers and/or the possible inability of B cells to 
differentiate into plasma cells with subsequent decrease in Ab 
112 
synthesis. Similar results were found in rabbits given immuno­
suppressive drugs.Opsonization of the conidla by Ab is potentially 
reduced because only 24% of Group 3 rabbits produced antibodies to A. 
fumlgatus. Complement activity in rabbits was not affected by T-2 
47 ingestion in this study, nor in studies with guinea pigs or 
monkeys.Therefore, opsonization may still occur, but at reduced 
efficiency, utilizing complement and the C3b receptors on the AM 
resulting in the Ab-independent alternate pathway mechanism of killing 
conidla. 
The initial decrease in all leukocyte numbers in Group 3 rabbits 
explains the decreased Inflammatory response seen in tissue sections. 
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This and other studies * ' have shown a resumption of hematopolesls 
(with the exception of lymphocytes)^^ after '2 to 3 weeks of T-2 toxin 
ingestion. The mechanism of recovery is not known, but could be 
explained by hepatic biotransformation of T-2 toxin into 
metabolites^^*that do not affect hematopolesls.^^ Interaction 
of other mycotoxins in natural T-2 mycotoxicoses also may influence 
hematopolesls. 
T-2 toxin is known to cause hypoplasia of bone marrow and splenic 
red pulp, followed by regeneration of hematopoietic cells after 
a p p r o x i m a t e l y  2  t o  3  w e e k s  o f  t o x i n  c o n s u m p t i o n . D i e t a r y  
studies with T-2 toxin showed that the suppression was generally 
unrelated to undernutrition.Marginal anemia, characterized in 
T-2 treated rabbits by the transient 5 to 12% decrease in PCV, is 
additional evidence of temporary hematopoietic suppression. T-2 toxin 
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was responsible for Che morphologic changes and reduced percent of 
erythrocytes in peripheral blood in Group 1 and 3 rabbits. Increased 
nucleated erythrocytes, observed on Days 14 and 21 in Group 1 and 3 
rabbits, suggest a regenerative anemia. This has been reported in 
other T-2 feeding studies.Numerous erythrocyte precursors 
were present throughout the splenic red pulp in histologic sections of 
29 69 
T-2 treated animals in this and other studies. * 
The greater numbers of CPU in ileal Beyer's patch and sacculus 
rotundus in Group 2A rabbits were likely due to normal efficient 
phagocytosis of conldia by AM and transport via the mucociliary 
escalator to the digestive tract. Lymphocyte necrosis and/or depletion 
of primary and secondary lymphoid tissues evident in Groups 1 and 3 are 
indicative of the immunocytotoxic effects of T-2 toxin.30,36 
The relative severity of germinal center lesions in secondary lymphoid 
tissues examined in this study, as well as from the previous experi-
33 
ment, was appendix > sacculus rotundus > ileal Peyer's patch > lymph 
node and spleen, which reflects the known proliferation rates of 
lymphoid cells in these organs.The immunosuppression by T-2 toxin 
in Group 3 rabbits resulted in more severe lesions in these tissues, 
with hyphae and conldia readily apparent in appendix and sacculus 
rotundus of only Group 3A rabbits. 
T-2 toxin is rapidly metabolized in the liver and is eliminated as 
glucuronide metabolite conjugates via the biliary excretion 
system.Other T-2 toxin studies have shown that depletion 
of hepatic-reduced glutathione transferase and/or production of free 
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radicals causing lipid peroxidation in the liver could contribute to 
hepatotoxicity.The hepatotoxlc effect of T-2 toxin was apparent in 
the rabbits in this study, whereby centrolobular hepatocellular 
swelling and vacuolation, hepatic portal and periportal fibrosis, and 
bile duct reduplication were seen. The evidence for hepatotoxicity and 
decreases in serum ALP and SDH concentrations may be due to reduced 
13 
synthesis in the liver. Alternatively, these changes may be due to 
interference in enzyme release caused by membrane alterations without 
78 
cell lysis. It is possible that the centrolobular hepatocellular 
swelling could have been a reflection of hypoxic change caused by 
anemia because some rabbits were marginally anemic as evidenced by a 
decreased PCV. 
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GENERAL SUMMARY AND DISCUSSION 
Few studies of the in vitro effects and ^  vivo chronic effects of 
T-2 toxin on cell mediated resistance to a variety of infectious 
diseases have been conducted.Even fewer studies have been 
reported in which the interaction of mycotoxins with mycoses 
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vitro or in vivo ' was examined. The interaction of T-2 toxin 
and aspergillosis has not been investigated. In this study, the rabbit 
was used as a model to test ^  vivo and vitro chronic effects of T-2 
toxin on the phagocytic and pathologic response to Aspergillus 
fumlgatus. 
Results of the first study indicate that T-2 toxin given orally at 
0.5 mg/kg/d for 21 days significantly reduced the in vitro phagocytic 
capacity of alveolar macrophages, apparently due to an unknown serum 
factor. Other physical parameters that were reduced at 0.5 mg/kg/d 
included weight gains, serum alkaline phosphatase, serum sorbitol 
dehydrogenase, and serum bacteriostasis. Oral dosages of 0.75 mg T-2 
toxin/kg/d caused mortality (4 of 5 rabbits) and decreases in PCV, 
total WBC, and differential leukocyte counts. Histopathologic changes 
consisting of centrolobular hepatocellular swelling, mild portal and 
periportal fibrosis were found in most T-2 treated rabbits. Addition­
ally, lymphocyte necrosis within secondary lymphoid tissue occurred in 
these rabbits. Thymic atrophy, bile duct reduplication, and lymphoid 
depletion of secondary lymphoid tissue occurred in the 0.75 mg/kg/d 
group. The changes observed in the liver have not been previously 
reported in other studies using T-2 toxin,whereas lymphocyte 
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necrosis and depletion have been typical changes observed in T-2 
Based on results from the first study, we then tested the hypothe­
sis that Ingestion of 0.5 mg T-2 toxin/kg/d by rabbits for 17 or 28 
days and exposure to aerosols of A. fumigatus conidia for 10 days would 
result in immunosuppression and reduced resistance to aspergillosis. 
The results of the second study proved this hypothesis to be correct. 
In the second study, changes caused by T-2 toxin included leuko­
penia, anemia, and increased numbers and morphologic changes in nucle­
ated erythrocytes by Day 21, followed by a regenerative response. Four 
of the rabbits given T-2 toxin died. Serum alkaline phosphatase and 
serum sorbitol dehydrogenase also were decreased by T-2 toxin inges­
tion. While aspergillosis in rabbits caused leukocytosis and an 
increased Ab response (IHA) to A. fumlgatus, T-2 toxin ingestion caused 
a decrease in the Ab response of rabbits exposed to aerosols of A. 
fumigatus conidia. Normal pulmonary defense mechanisms to A. fumigatus 
infection were compromised by T-2 treatment, as evidenced by the 
severity and extent of lung lesions, greater numbers of hyphal elements 
observed in lesions, and greater numbers of A. fumigatus colony-forming 
units (CPU) isolated from these rabbits. Histopathologic changes 
consisting of centrolobular hepatocellular swelling, portal and peri­
portal fibrosis, and lymphocyte necrosis and/or depletion within 
secondary lymphoid tissue occurred in most T-2 treated rabbits. 
These studies have provided evidence that normal phagocytic and 
cell mediated immune defense mechanisms to A. fumigatus infection were 
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compromised by oral dosages of 0.5 mg T-2 toxin/kg/d. In addition, 
they have contributed to a better understanding of pathologic, 
hematologic, serologic, and mycologic changes in rabbits given T-2 
mycotoxin orally and exposed to aerosols of A. fumigatus conidia. 
128 
LITERATURE CITED 
1. Joffe AZ. Foodborne diseases: alimentary toxic aleukia. In: 
Rochclgle, M, ed. Handbook of Foodborne Disease of Biological Origin. 
Boca Ratan, Florida:CRC Press, 1983. 
2. Scott PM, Harwig J, Blanchfield BJ. Screening Fusarlum 
strains isolated from overwintered Canadian grains for Trlchothecens. 
Mycopathologia 1980;72:175-180. 
3. Ueno Y. Trlchothecenes: overview address. In: Rodrlcks JV, 
Hesseltine CW and Mehlman MA, eds. Mycotoxlns in Human and Animal 
Health. Park Forest South, IL:Pathtox., 1977;189-208. 
4. Ueno Y. General toxicology. In: Ueno, Y, ed. 
Trlchothecenes-Chemlcal, Biological and Toxlcologlcal Aspects, 
Developments in Food Science; 4. New York:Elsevier, 1983;4:135-146. 
5. Hsu IC, Smalley EB, Strong FM, et al. Identification of T-2 
toxin in moldy corn associated with a lethal toxicosis in dairy cattle. 
Appl Microbiol 1972;24:684-690. 
6. Petrle L, Robb J, Stewart AF. The identification of T-2 
toxin and its association with haemorrhagic syndrome in cattle. Vet 
Rec 1977;101:326-327. 
7. Greenway JA, Puis R. Fusariotoxicosis from barley in British 
Columbia. I. Natural occurrence and diagnosis. Can J Comp Med 
1976;40:12-15. 
8. Mayer CF. Endemic panmyelotoxlcosls in the Russian grain 
belt. Part one: the clinical aspects of alimentary toxic aleukia 
(ATA). A comprehensive review. Mil. Surg. 1953a;113:173-189. 
129 
9. Mayer CF. Endemic panmyelotoxicosls in the Russian grain 
belt. Part two: the botany, phytopathology, and toxicology of Russian 
cereal food. Mil. Surg. 1953b;113:295-315. 
10. Richard JL, Thurston JR, eds. In: Diagnosis of 
Mycotoxicoses. Boston:Martinus Nijhoff Publishers, 1986;411 pp. 
11. Rippon JW. In: Medical Mycology, The Pathogenic Fungi and 
the Pathogenic Actinomycetes. Second ed. Philadelphia:WB Saunders 
Company, 1982:565-594. 
12. Richard JL. Respiratory diseases of fungal origin in cattle, 
horses and swine. In: Proceedings of Annual Conference for 
Veterinarians, Iowa State University, Ames, lA., 1978. 
13. Zook BC, Migaki G. Aspergillosis in animals. In: A1 Doory 
Y, Wagner GE, eds. Aspergillosis. Springfield:Charles C. Thomas, 
Publisher, 1985:274 pp. 
14. Lacey J, ed. In: Trichothecenes and Other Mycotoxins. New 
York;John Wiley and Sons, 1985;571 pp. 
15. Godtfredsen WO, Grove JF, Tamm CH. On the nomenclature of a 
new class of sesquiterpenes. Helv Chim Acta 1967;50:1666-1668. 
16. Freeman GG, Morrison RI. Trichothecin: An antifungal 
metabolic product of roseum Link. Nature 1948;162:30. 
17. Freeman GG, Morrison RI. The isolation and chemical 
properties of trichothecin, an antifungal substance from Trichothecium 
roseum Link. Biochem J 1949;44:1-5. 
130 
18. Hamburg JR. Biological and biochemical actions of 
trichothecene mycotoxlns. In; Hahn FE, ed. Progress In Molecular and 
Subcellular Biology. BerlinrSprlnger-Verlag, 1983;8:41-110. 
19. Smalley EB, Strong FM. Toxic Trlchothecenes. In; Purchase 
IFH, ed. Mycotoxlns. New York;Elsevler Scientific Publishing Co., 
1974,-199-228. 
20. Snyder WC, Hansen HN. The species concept in Fusarlum with 
reference to discolor and other sections. Am J Bot 1945;32;657-666. 
21. Hamburg JR, Rlgg NV, Strong FM. The structures of toxins 
from two strains of Fusarlum trlcinctum. Tetrahedron 
1968;24;3329-3336. 
22. Marasas WFO, Nelson PE, Toussoun TA. In: Toxigenic Fusarlum 
Species Identity and Mycotoxlcology. University Park:The Pennsylvania 
State University Press, 1984;328 pp. 
23. Wei RD, Smalley EB, Strong FM. Improved skin test for 
detection of T-2 toxin. Appl Microbiol 1972;23;1029-1030. 
24. Chu FS, Grossman S, Wei RD, et al. Production of antibody 
against T-2 toxin. Appl Environ Microbiol 1979;37:104-108. 
25. Lee S, Chu FS. Radioimmunoassay of T-2 toxin in biological 
fluids. J Assoc Off Anal Chem 1981;64;684-688. 
26. Lee S, Chu FS. Radioimmunoassay of T-2 toxin in corn and 
wheat. J Assoc Off Anal Chem 1981;64:151-161. 
27. Pestka JJ, Lee SC, Lau HP, et al. Enzyme-linked 
Immunosorbent assay for T-2 toxin. J Am Oil Chem Soc 
1981;58:940A-944A. 
131 
28. Woronln M. Ijber das "Taumel-getreide" in Sud-Ussurien, Bot 
Z 1891;49:81-93. 
29. Wyatt RD, Harris JR, Hamilton PB, et al. Possible outbreaks 
of Fusarlotoxlcosis In avians. Avian Dis 1972;16:1123-1130. 
30. Wade N. Yellow rain and the cloud of chemical war. Science 
1981;214:1008-1009. 
31. Rosen JD. Presence of mycotoxlns and a man-made material In 
a yellow rain sample. Arch Belg Med Soc Hyg Med Trav Med Leg. Proc 
1st World Congr Suppl. 1984:173-176. 
32. Nowlcke JW, Meselson M. Yellow rain - a palynologlcal 
analysis. Nature 1984;309:205-206. 
33. Heyndrlckx A, Sookvanlchsllp N, Van Den Heede M. Detection 
of trichothecene mycotoxlns (yellow rain) In blood, urine and faeces of 
Iranian solders treated as victims of a gas attack. Arch Belg Med Soc 
Hyg Med Trav Med Leg, Proc 1st World Congr Suppl 1984:143-146. 
34. Gyongyossy-Issa MIC, Card RT, Fergusso DJ, et al. 
Prehemolytic erythrocyte deformability changes caused by trichothecene 
T-2 toxin - an ektacytometer study. Blood Cells 1986;11:393-403. 
35. Gyongyossy-Issa MIC, Card RT, Fergusso DJ, et al. 
Prehemolytic erythrocyte deformability changes caused by trichothecene 
T-2 toxin - an ektacytometer study. Reply to commentary. Blood Cells 
1986;11:407. 
36. Gyongyossy-Issa MIC, Khanna V, Khachatourians GG. Changes 
Induced by T-2 toxin in the erythrocyte membrane. Fd Chem Toxicol 
1986;24:311-317. 
132 
37. Gyongyossy-Issa MIC, Khachatourians GG. Interaction of T-2 
toxin and murine lymphocytes and the demonstration of a threshhold 
effect on macromolecular synthesis. Biochim Biophys Acta 
1985;844:167-173. 
38. Rosenstein Y, LaFarge-Frayssinet C. Inhibitory effect of 
Fusarium T-2-toxin on lymphoid DNA and protein synthesis. Toxicol Appl 
Pharmacol 1983;70:283-288. 
39. Gyongyossy-Issa MIC, Khachatourians GG. Interaction of T-2 
toxin with murine lymphocytes. Biochim Biophys Acta 1984;803:197-202. 
40. Cundliffe E, Davis J. Inhibition of initiation, elongation 
and termination of eukaryotic protein synthesis by trichothecene fungal 
toxins. Antimicrob Agents Chemother 1977;11:491-499. 
41. Gyongyossi-Issa MIC, Khanna V, Khachatourians GG. 
Characterisation of hemolysis induced by T-2 toxin. Biochim Biophys 
Acta 1985;838:252-256. 
42. Segal R, Milo-Goldzweig I, Joffe AZ, et al. 
Trichothecene-induced hemolysis. I. The hemolytic activity of T-2 
toxin. Toxicol Appl Pharmacol 1983;70:343-349. 
43. Terao K. The target organella of trichothecenes in rodents 
and poultry. In: Ueno Y, ed. Trichothecenes - Chemical, Biological 
and Toxicological Aspects, Developments in Food Science: 4. New York: 
Elsevier, 1983;4:147-162. 
133 
44. Thurston JR, Richard JL, Peden WM. Immunomodulation in 
mycotoxlcoses other than aflatoxlcosis. In: Richard JL, Thurston JR 
eds. Diagnosis of Mycotoxlcoses. BostoniMartlnus Nljhoff Publishers 
1986;149-161. 
45. Corley RA, Swanson SP, Gullo GJ, et al. Disposition of T-2 
toxin, a trlchothecene mycotoxln, in intravascularly dosed swine. 
Agrlc Food Chem 1986;34:868-875. 
46. Lafarge-Frayssinet C, Lespinats G, Lafont P, et al. 
Immunosuppressive effects of Fusarium extracts and trichothecenes: 
blastogenic response of murine splenic and thymic cells to mitogens 
(40439). Proc Soc Exp Biol Med 1979;160:302-311. 
47. Corrier DE, Ziprln RL. Immunotoxic effects of T-2 toxin on 
cell-mediated immunity to listeriosis in mice: comparison with 
cyclophosphamide. Am J Vet Res 1986;47:1956-1960. 
48. Hayes MA, Bellamy JEC, Schiefer HB. Subacute toxicity of 
dietary T-2 toxin in mice: morphological and hematological effects. 
Can J Comp Med 1980;44:203-218. 
49. DeNlcola DB, Rebar AH, Carlton WW, et al. T-2 toxin 
mycotoxicosis in the guinea pig. Food Cosmet Toxicol 1978;16:601-609. 
50. Pace JG. Effect of T-2 mycotoxln on rat liver mitochondria 
electron transport system. Toxlcon 1983;21:675-680. 
51. Schiller CM, Yagen B. Inhibition of mitochondrial 
respiration by trlchothecene toxins from Fusarium sporotrichioides. 
Fed Proc 1981;40:1579. 
134 
52. Beasley VR, Swanson SP, Corley KA, et al. Pharmacokinetics 
of the trlchothecene mycotoxln, T-2 toxin. In swine and cattle. 
Toxlcon 1986;24:13-23. 
53. Yoshlzawa T, Mlrocha CJ, Behrens JC, et al. Metabolic fate 
of T-2 toxin in a lactating cow. Food Cosmet Toxicol 1981;19:31-39. 
54. Corley KA, Swanson SP, Buck WB. Glucuronide conjugates of 
T-2 toxin and metabolites in swine bile and urine. J Agric Food Chem 
1985;33:1085-1089. 
55. LaFargo-Frayssinet CF, DeCloitre F, Mousset S, et al. 
Induction of DNA single-strand breaks by T-2 toxin, a trlchothecene 
metabolite of Fusarlum: effect on lymphoid organs and liver. , Mutat Res 
1981;88:115-123. 
56. Hsia CC, Gao Y, Wu J, et al. Induction of chromosome 
aberrations by Fusarlum T-2 toxin in cultured human peripheral blood 
lymphocytes and Chinese hamster fibroblasts. J Cell Physiol 
1986;4:65-72. 
57. Schoental R, Joffe AZ, Yagen B. Cardiovascular lesions and 
various tumors found in rats given T-2 toxin, a thrlchothecene 
metabolite of Fusarlum. Cancer Res 1979;39:2179-2189. 
58. Hayes AW. In: Mycotoxln Teratogenicity and Mutagenicity. 
Boca Raton:CRC Press, Inc., 1981;60-63. 
59. Buenlng GM, Mann DD, Hook B, et al. The effect of T-2 toxin 
on the bovine immune system: cellular factors. Vet Immunol Immunopath 
1982;3:411-417. 
135 
60. Niyo KA, Richard JL, Niyo Y, et al. Effects of T-2 mycotoxin 
ingestion on phagocytosis of Aspergillus fumigatus conidia by rabbit 
alveolar macrophages and on hematologic, serum biochemical and 
pathologic changes in rabbits. Manuscript in preparation. National 
Animal Disease Center, Ames, lA. 
61. Gerberick GF, Sorenson WG. Toxicity of T-2 toxin, a Fusarlum 
mycotoxin, to alveolar macrophages dja vitro. Environ Res 
1983;32:269-285. 
62. Gerberick GF, Sorenson WG, Lewis DM. The effects of T-2 
toxin on alveolar macrophage function vitro. Environ Res 
1984;33:246-260. 
63. Rosenstein Y, Lafarge-Frayssinet C, Lespinats G, et al. 
Immunosuppressive activity of Fusarium toxins. Effects on antibody 
synthesis and skin grafts of crude extracts, Tg-Coxin and 
diacetoxyscirpenol. Immunology 1979;36:111-117. 
64. Forsell JH, Kateley JR, Yoshizawa T, et al. Inhibition of 
mitogen-induced blastogenesis in human lymphocytes by T-2 toxin and its 
metabolites. Appl Environ Microbiol 1985;49:1523-1526. 
65. Cooray R. Effects of some mycotoxins on mitogen-induced 
blastogenesis and SCE frequency in human lymphocytes. Food Chem 
Toxicol 1984;22:529-534. 
66. Chan PK-C, Gentry PA. Inhibition of bovine platelet function 
by T-2 toxin, HT-2 toxin, diacetoxyscirpenol and deoxynivalenol. Food 
Chem Toxicol 1984;22:643-647. 
136 
67. Yarom R, Sherman Y, More R, et al. T-2 toxin effect on 
bacterial infection and leukocyte functions. Toxicol Appl Pharmacol 
1984;75;60-68. 
68. Jagadeesan V, Rukmini C, Vijayaraghavan M, et al. Immune 
studies with T-2 toxin: effect of feeding and withdrawal in monkeys. 
Food Chem Toxicol 1982;20:83-87. 
69. Lutsky I, Mor N, Yagen B, et al. The role of T-2 toxin in 
experimental alimentary toxic aleukia: a toxicity study in cats. 
Toxicol Appl Pharmacol 1978;43:lll-i24. 
70. Sato N, Ueno Y, Enomoto M. Toxicologlcal approaches to the 
toxic metabolites of Fusaria. VIII. Acute and subacute toxicities of 
T-2 toxin in cats. Japan J Pharmacol 1975;25:263-270. 
71. Yarom R, Yagen B. T-2 toxin effect on the ultrastructure of 
myocardial microvasculature. Br J Exp Pathol 1986;67:55-63. 
72. Richard JL, Cysewski SJ, Pier AC, et al. Comparison of 
effects of dietary T-2 toxin on growth, immunogenic organs, antibody 
formation, and pathologic changes in turkeys and chickens. Am J Vet 
Res 1978;39:1674-1679. 
73. Osweller GD. Occurrence and clinical manifestations of 
trichothecene toxicoses and zearalenone toxicoses. In: Richard JL, 
Thurston JR, eds. Diagnosis of Mycotoxicoses. Boston:Martinus Nijhoff 
Publishers, 1986;31-42. 
74. Richard JL, Thurston JR, Pier AC. Effects of mycotoxins on 
immunity. Proc. 5th Intl. Symp. Toxins: Animal, Plant and Microbial, 
Pergamon, New York, 1978;801-817. 
137 
75. Kanal K, Kondo E. Decreased resistance to mycobacterial 
infection in mice fed a trlchothecene compound (T-2 toxin). Jpn J Med 
Scl Biol 1984;37:97-104. 
76. Boonchuvit B, Hamilton PB, Burmelster HR. Interaction of T-2 
toxin with Salmonella infections in chickens. Poult Scl 
1975;54:1693-1696. 
77. Friend SCE, Schleffer HB, Babluk LA. The effects of dietary 
T-2 toxin on acute herpes simplex virus Type 1 infection in mice. Vet 
Pathol 1983;20:737-760. 
78. Corrier DE, Ziprln RL. Immunotoxic effects of T-2 mycotoxln 
on cell-mediated resistance to Listeria monocytogenes Infection. Vet 
Immunol Immunopathol 1987;14:11-21. 
79. Bardana EJ. The clinical spectrum of aspergillosis - Part 1: 
epidemiology, pathogenicity, infection in animals and Immunology of 
Aspergillus. CRC Crlt Rev Clin Lab Scl 1980;13:21-83. 
80. Raper KB, Fennell DI. In: The Genus Aspergillus. 
Baltimore:The Williams and Wilkins Company, 1965;686 pp. 
81. McGlnnis MR. In: Laboratory Handbook of Medical Mycology. 
New York:Academlc Press, 1980;661 pp. 
82. Pare JAP, Fraser RG. In: Synopsis of Diseases of the Chest. 
Philadelphia:W.B. Saunders Co., 1983;389-394. 
83. Diamond RD, Krzesicki R, Epslein B, et al. Damage to hyphal 
forms by human leukocytes in vitro. Am J Pathol 1978;91:313-323. 
138 
84. Marsh PB, Millner PD, Kla JM. A guide to the recent 
literature on aspergillosis as caused by Aspergillus fumigatus, a 
fungus frequently found in self-heating organic matter. Mycopathologia 
1979;69:67-81. 
85. Karam GH, Griffin FM, Jr. Invasive pulmonary aspergillosis 
in nonimmunocompromised, nonneutropenic hosts. Rev Infect Pis 
1986;8:357-363. 
86. Pennington JE. Aspergillus lung disease. Med Clin NA 
1980;64:475-490. 
87. Marier R, Smith W. A solid phase radioimmunoassay for the 
measurement of antibody to Aspergillus in invasive aspirgillosis. £ 
Infect Pis 1979;140:771-779. 
88. Richardson MP, White LO. Petection of circulating antigen of 
Aspergillus fumigatus sera of mice and rabbits by enzyme-linked 
immunosorbent-assay. Mycopathologia 1979;67:83-88. 
89. Reiss E, Lehman PF. Galatomannan antigenemia in invasive 
aspergillosis. Infect Immun 1979;25:357-365. 
90. Weiner MH, Talbot GH, Gerson SL, et al. Antigen detection in 
the diagnosis of aspergillosis. Utility in controlled, blinded trials. 
Ann Intern Med 1983;99:777-782. 
91. Cordes PO, Podd PC, O'Hara PJ. Acute mycotic pneumonia of 
cattle. New Zealand Vet J 1964;12:101-104. 
92. Austwick PKC. The presence of Aspergillus fumigatus in the 
lungs of dairy cows. Lab Invest 1962;11:1065-1072. 
139 
93. Klrkbrlde CA, Blcknell EJ, Reed DE, et al. A diagnostic 
survey of bovine abortion and stillbirth In the Northern Plains states. 
J Am Vet Med Assoc 1973;162:556-560. 
94. Austwlck PKC, Venn JAJ. Mycotic abortion In England and 
Wales,1954-1960. In; Proceedings, 4th Intl Cong An Reproduc. The 
Hague, Netherlands, 1961;3:562-568. 
95. Krogh P, Bosse A. The pathogenesis of bovine mycotic 
abortion: An experimental study. In; Proceedings 5th Intl Congr, 
Intl Soc Human & An Mycol. Paris, 1971. 
96. Chute HL. Fungal Infections. In: Hofstad MS, Barnes HJ, 
Calnek BW, Reld WM, Yoder HW Jr., eds. Diseases of Poultry. 8th Ed. 
Ames, IA:Iowa State Univ. Press, 309-322. 
97. Peden WM, Richard JL, Trampel DW, et al. Mycotic pneumonia 
and meningoencephalitis due to Aspergillus terreus In a neonatal snow 
leopard (Panthera uncla). J Wildlife Dis 1985;21:301-305. 
98. Fromentin H, Salazar-Mejlcanos S, Marlat F. Pouvoir 
pathogene de Candida albicans pour la souris normale ou deprlmee par 
une mycotoxlnl: le dlacetoxysclrpenol. Annales de Microbiologie 
1980;131B:39-46. 
99. Fromentin H, Salazar-Mejlcanos S, Marlat F. Experimental 
cryptococcosis In mice treated with dlacetoxysclrpenol, a mycotoxln of 
Fusarlum. Sabouraudla 1981;19:311-313. 
100. Richard JL, Thurston JR. Effect of aflatoxln on phagocytosis 
of Aspergillus fumlgatus spores by rabbit alveolar macrophages. Appl 
Microbiol 1975;30:44-47. 
140 
ACKNOWLEDGMENTS 
I wish to thank the many individuals who have contributed to my 
completion of this degree. To my children, John, Gary, and Kary, and 
my father, Ernest Jacobson, I thank you for your patience, help, and 
many words of encouragement. A special thank you to John for your 
responsible maturity in my many absences, for being my computer 
instructor, my delightful companion, and my special friend. 
To my co-major professors, Dr. Lois H. Tiffany and Dr. John L. 
Richard, I thank you for providing me with the opportunity of pursuing 
an advanced degree. I appreciate your models of perfection, excellence 
in teaching, and the provision of many hours of personal instruction, 
moral support, and guidance. 
I am grateful for having had the opportunity to participate in the 
Immunobiology Interdepartmental Program, initially chaired by the late 
Dr. Patricia M. Gough and currently under the able guidance of 
Dr. James A. Roth. Further thanks are expressed to Drs. Roth, 
Gary D. Osweiler, and Harry T. Horner, who served as excellent 
committee members. 
Gratitude is expressed to Dr. Yosiya Niyo for competent histo­
pathologic evaluation of tissues and excellent editorial comments on 
the manuscripts, to Dr. W. Michael Peden for necropsy assistance and 
pathologic consultations, to Rebecca L. Lyon and Rodney E. Fichtner for 
expert technical assistance, to Dr. John R. Thurston and Kim M. 
Driftmier for assistance with serology and animal care, to Wayne A. 
Romp, Gene L. Hedberg, and Tom L. Glasson of the Photographic Unit at 
141 
the National Animal Disease Center, for the excellent plates and 
graphs, to Janice K. Eifling and staff for constant library support, to 
the ISU Graduate College for their support, and to Janice M. Olson and 
Annette L. Bates for expert typing of this manuscript. 
I especially thank all those individuals in the Agricultural 
Research Service and the National Animal Disease Center who provided 
support for me to work as a Research Assistant for 2-3/4 years at the 
NADC under the Research Support Agreement Program. I am greatly 
appreciative of this unique educational opportunity provided to me by 
Drs. Phillip A. 0'Berry, George Lambert, Norman F. Cheville, and 
John L. Richard. , 
